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ABSTRACT 
 
 Trafficking of protein and lipid cargo through the secretory pathway in eukaryotic 
cells is mediated by membrane-bound vesicles. Secretory vesicles are targeted to sites of 
exocytosis on the plasma membrane in part by a conserved multi-subunit protein complex 
termed the exocyst. In addition to tethering vesicles to the plasma membrane, the exocyst 
complex and components therein may also add a layer of regulation by directly 
controlling assembly of the SNARE complex, which is required for membrane fusion, as 
well as other regulatory factors such as Sec1p. In the past, we have shown that Sec6p 
interacts with Sec9p in vivo and that that interaction retards binary SNARE complex 
formation in a SNARE assembly assay. Though many interactions have been mapped 
using in vitro methods, confirming them in vivo and placing them into the context of a 
complete model that accounts for all observed interactions (and lack of interactions) has 
proven difficult.  
 In order to address these problems, I have studied the interactions between Sec6p 
and other factors involved in exocytosis at the plasma membrane via in vivo methods. My 
hypothesis was that Sec6p interaction with Sec9p and subsequent inhibition of SNARE 
complex assembly in vitro was an intermediate state and Sec6p was part of a set of 
cofactors that accelerated SNARE complex assembly in vivo. To test this hypothesis I 
showed that the interaction between the plasma membrane t-SNARE Sec9p and the yeast 
exocyst subunit Sec6p can be observed in vivo and designed point mutations to disrupt 
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that interaction. Interestingly, I also showed that Sec6p:Sec9p interaction involves the 
free pool of Sec6p rather than the exocyst bound fraction of Sec6p. 
 Point mutations in the N-terminal domain of Sec6p result in temperature sensitive 
growth and secretion defects, without loss of Sec6p-Sec9p interaction. However, at the 
non-permissive temperature, the exocyst subunits Sec5p, Sec10p and Sec15p are 
mislocalized and are absent from the exocyst complex. The resulting subcomplex, 
containing Sec3p, Sec8p, Exo70p and Exo84p, remains stably assembled and localized at 
sites of polarized secretion. This subcomplex is likely due to disruption of interaction 
between Sec6p and Sec5p, and may be similar to that observed at restrictive temperatures 
in the sec6-54 temperature sensitive mutant.  
 Additionally, one of the sec6 temperature sensitive mutants displays a loss of 
binding to the yeast regulatory protein Sec1p. In vitro binding studies indicate a direct 
interaction between Sec1p and the free pool of the wild-type Sec6p protein, suggesting 
close interplay between Sec6p and Sec1p in the regulation of SNARE complexes. A 
coherent model which incorporates all these interactions has continued to be elusive. 
However, the results I have found do suggest several hypotheses which should prove 
testable in the future. 
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Trafficking and the eukaryotic cell 
A defining feature of the eukaryotic cell, from single-celled yeast to complex 
metazoans like humans, is the organelle. Organelles are compartments that delineate 
spatially and chemically distinct features and allow both spatial and temporal separation 
of eukaryotic processes. For example, protein synthesis of proteins destined for secretion 
or membrane insertion occurs within the endoplasmic reticulum (ER), where mRNA is 
translated and proteins are folded for secretion or insertion into membrane. Proteins that 
require post-translational modification may be processed in the Golgi apparatus. Some 
carbohydrate synthesis also occurs here. Proteins on their way to degradation may then 
pause in the early and late endosomes, organelles that can mature into lysosomes and also 
process endocytic trafficking from the plasma membrane to the Golgi. The lysosome, or 
vacuole in yeast, sequesters and degrades proteins, membranes, and other molecular 
cargo via resident enzymes, thus providing a “garbage disposal” for the eukaryotic cell.  
Finally, proteins, membranes, and other cargo destined for secretion find their way to the 
plasma membrane, the surface of the cell where exocytosis is completed.  
Each of these organelles, or compartments, is surrounded by a membrane that 
sequesters the contents from other organelles and from the cytosol that fills the space 
between organelles. This compartmentalization allows a lysosome to have a low pH and 
proteases that would be harmful, if not lethal, to the rest of the cell. However, the 
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compartmentalization that allows for complex eukaryotic life, like most solutions, creates 
another problem that must be solved.  
The problem created by the strict delineation of membrane-bound organelles is 
one of transport. How does a cell that is divided into distinct organelles move proteins, 
macromolecules, and lipids between those compartments to ensure the continuation of 
essential processes such as growth and secretion? Vesicular trafficking, the movement 
and delivery of cargo and membrane between spatially and chemically distinct 
organelles, is an essential and highly conserved process in all eukaryotes 1. There are 
several requirements that trafficking must meet if it is to be effective. Trafficking must be 
fast. It must occur within the timescale of living processes. Trafficking must also be 
targeted and have high fidelity. Cargoes must reach their destinations and only their 
destinations. Otherwise, for example, membrane needed for plasma membrane growth 
risks being degraded in the vacuole. To ensure that these trafficking processes occur 
efficiently and effectively requires a host of proteins. Vesicular trafficking is highly 
conserved among eukaryotes. Because of this evolutionary conservation, we can use the 
budding yeast Saccharomyces cerevisiae, a genetically tractable, easily grown eukaryote, 
as a model organism for research that will apply across the eukaryotic spectrum, 
including humans. This thesis focuses on vesicular trafficking in S. cerevisiae.   
Trafficking is a conserved process in eukaryotes 
 Trafficking can be divided into five conserved steps (Figure 1.1) including (1) 
budding, (2) transport, (3) tethering, (4) docking, and (5) fusion. I will discuss all of these  
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Figure 1.1 The five conserved steps of trafficking. The steps of trafficking and classes 
of proteins are represented schematically. 1) Vesicle buds from the donor organelle 
membrane. 2) Vesicle is trafficked through the cytosol along the cytoskeleton. 3) Vesicle 
is loosely associated with target membrane via tethering factors interacting with small 
GTPases. 4) SNARE complexes are formed and the vesicle docks with the target 
membrane. 5) SNARE complexes complete formation and membranes fuse, releasing 
vesicle contents into the target organelle and merging the membranes. 
18 
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in detail later. Briefly, budding (1) is the formation of a cargo-carrying vesicle from the 
membrane of a donor organelle. Budding occurs when coat proteins, such as clathrin, 
COPI and COPII complexes, associate with the donor membrane and oligomerize to form 
large complexes, shaping a vesicle 1-3. Transport (2) of the budded vesicles from the 
donor membrane to the target membrane occurs along either microtubules or actin 
filaments via interactions with the myosin and dynein classes of molecular motors 4. 
Tethering (3) occurs when the vesicle arrives at the target membrane, and is defined as 
the formation of a reversible, often long distance, interaction between the target and 
vesicle membrane. This interaction occurs before docking and involves “tethering 
factors” 1,5,6. Docking (4) is the formation of an irreversible link between the vesicle and 
target membrane via the formation of a fusion-competent SNARE (soluble NSF 
attachment receptor) protein complex 1,7. Fusion (5) with the target membrane is the final 
step of trafficking. Cargo is released into the target organelle or extracellular space when 
the vesicle membrane merges with the membrane of the target organelle 1,7,8. 
 These basic steps are conserved both between organisms (S. cerevisiae trafficking 
is similar to H. sapiens trafficking) and between organelles (Golgi-plasma membrane 
trafficking is similar to ER-Golgi trafficking). Additionally, anterograde trafficking 
towards the plasma membrane, exocytosis, is similar to retrograde trafficking towards the 
nucleus, endocytosis. This poses another challenge for the eukaryotic cell. Not only is 
trafficking between these sealed organelle compartments essential, but trafficking 
between different organelles is a structurally very similar process. So how does a cell 
maintain the fidelity of vesicular trafficking? How does it ensure that cargo destined for 
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the Golgi apparatus is trafficked only to the Golgi apparatus, and, once the cargo has 
arrived, that it fuses only with the Golgi apparatus? 
The solution is multiple layers of protein families that are conserved in the same 
manner as the trafficking steps themselves. These proteins ensure that cargo is trafficked 
to the proper organelle, at the proper time, and fuses in the proper place 1,8-10. The 
majority of these proteins are essential; without them the cell cannot survive even under 
ideal conditions. Mutations in most trafficking proteins cause disease or, often, cell death 
11-15. Due to the fundamental and ubiquitous nature of the trafficking process, it is 
unknown how many diseases and malfunctions of the biological system result from 
defects in endo/exocytosis. The proteins involved in trafficking are numerous. In this 
thesis I will deal largely with the families of proteins involved in the Tethering, Docking, 
and Fusion (Figure 1.1 steps 3-5), and more specifically with those proteins involved in 
exocytic trafficking from the Golgi apparatus to the plasma membrane: coat proteins, 
small GTPases, tethering factors, SNARE proteins, and Sec1/Munc18 (SM) proteins. The 
trafficking process begins with budding by coat proteins. 
Coat Proteins 
The major coat proteins in S. cerevisiae are clathrin, COPI, and COPII 1,2. Coat 
proteins provide the primary force for vesicle formation (Figure 1.1 light blue proteins). 
Additionally these proteins provide regulation of cargo specificity and targeting through 
several mechanisms. First, they aid in the selection of membrane cargo, ensuring that 
cargo is loaded into the forming vesicle and non-cargo is excluded. Second, coat proteins 
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interact with Arf/Sar GTPases, which control both construction and deconstruction of the 
coat.  If the GTPases dissociate from coat proteins before membrane fission, the forming 
vesicle will not bud and will instead be resorbed by the donor organelle 1,3,2. Additionally, 
the coat confers specificity of targeting via direct interactions with motor and tethering 
proteins 3,9,14. In addition to being controlled by coat proteins, budding is also regulated 
by small GTPases. 
Small GTPases 
Small GTPases play a role in many, if not most, processes in the cell, including all 
steps of trafficking from coat formation and budding to fusion at the target organelle 
(Figure 1.1 pink proteins). The superfamily of small GTPases is subdivided into five 
families, the Ras, Rho/Rac/Cdc42, Rab, Sar1/Arf and Ran families. The small GTPases 
of the Ras superfamily are involved in processes that range from acting as signaling hubs, 
to directing coat protein interaction, to regulating all steps of trafficking 16-19.  
Each group of small GTPases regulates a specific subset of processes. The 
founding group of the Ras superfamily, the Ras GTPases are required for signal 
transduction to the nucleus for cell growth, survival, and differentiation 19,20. As 
mentioned above, the Sar1/Arf family of small GTPases regulates vesicle budding via 
regulation of coat formation 20. Ran GTPases are essential for trafficking in and out of the 
nucleus and for mitosis 19,20. The Rho GTPases are involved in cytoskeletal regulation, 
gene expression, cell polarity, and motility 19,20. Finally, the Rab GTPases regulate vesicle 
trafficking with individual Rabs localized to particular compartments, identifying 
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particular vesicles for specific target organelles 19. Recent data has demonstrated they also 
play crucial regulatory roles as late as the final fusion step of exocytosis. In this paradigm 
small GTPases function both as spatial regulators and regulators of the target membrane, 
possibly directly controlling deformation of the membrane prior to fusion 21,22. Most 
relevant to this thesis are the Rab and Rho/Rac/Cdc42 families.  
 Small GTPases cycle between two states: an active GTP-bound (guanosine 
triphosphate) state and an inactive GDP-bound (guanosine diphosphate) state. While 
active (GTP-bound), they bind to highly specific protein partners, defined as “effectors” 
to carry out diverse functions. In exocytosis, these functions include interaction with the 
forming and collapsing vesicle coat 1, spatial regulation of fusion 22, and interaction with 
tethering factors 23.  
When the GTP associated with the GTPase is hydrolyzed, losing a phosphate 
group to become GDP (the GTPase then entering the so called “GDP-bound” state), the 
GTPase dissociates from the effector, effectively “switching off” the process mediated by 
the effector19. Small GTPases are further regulated by GDI (guanine nucleotide 
dissociation inhibitor) and GEF (guanine nucleotide exchange factor) proteins that 
regulate the binding and exchange of GTP and GDP 20. These features make GTPases 
ideal regulators, allowing both spatial and temporal control of various processes. For 
example, when the small GTPase Sar1p interacts with its GEF protein and becomes GTP 
bound, a conformational change occurs. This reveals a small hydrophobic tail, anchoring 
Sar1p to the membrane. Once bound to the membrane, Sar1p recruits components of the 
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COPII vesicle coat, initiating budding. The coat can then be disassembled when Sar1p 
hydrolyzes bound GTP to GDP and dissociates from the membrane as the hydrophobic 
tail retracts 24. Small GTPases form a first line of regulation. They assure that vesicles 
bud when appropriate and bind to the correct motors, via direct and indirect interactions 
17,19,20,25. This ensures trafficking to the correct organelles, where small GTPases then 
interact specifically with appropriate tethering factors so fusion occurs only with the 
target organelle.  
SNARE Proteins 
SNARE proteins form the core of the fusion machinery (Figure 1.1 green 
proteins) 26. The SNAREs are a group of highly conserved proteins that interact via ~60 
residue “SNARE motifs” to form a four-helix coiled-coil complex that bridges the vesicle 
and target membrane (Figure 1.2) 27-31. The formation of this complex occurs in a parallel 
manner, like a zipper, from the N-termini to the C-termini of the SNAREs and is 
proposed to carry energy sufficient to initiate fusion of the vesicle and target membranes 
7,26,32-36. SNARE complexes always contain four SNARE motifs, but there may be three or 
four proteins utilized 26,37,38. For example in exocytosis between the Golgi apparatus and 
the plasma membrane, three SNARE proteins are utilized, one of which, Sec9p, provides 
two SNARE motifs to the complex 37.  All complexes, however, are formed from one 
SNARE motif associated with the vesicle and three associated with the target membrane 
31. Most, though not all, SNARE proteins are anchored in the relevant membrane via  
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Figure 1.2 The yeast exocytic four-helix SNARE complex represents a conserved 
architecture. The crystal structure of the fusion-competent yeast exocytic SNARE 
complex, (pdb 3B51) includes the t-SNARE Sec9p, v-SNARE Snc2p, and Syntaxin t-
SNARE Sso1p. Sso1p and Snc2p are anchored in the plasma and vesicle membranes 
respectively by transmembrane domains. The loop connecting the two helical domains of 
Sec9p, the liner regions, and transmembrane domains have been modeled in as they were 
not present in the crystal structure. It is unknown how Sec9p is localized to the plasma 
membrane. Image rendered using Pymol (pymol.org) 
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either transmembrane domains or reversible post-translational modifications such as 
palmitoylation 7,39. 
There are several classifications into which SNARE proteins can be divided. This 
thesis will use the locational descriptors, so-called “v-SNAREs” on the vesicle membrane 
and “t-SNAREs” on the target membrane 30. The t-SNAREs can be further divided into 
“syntaxin t-SNAREs” that are structurally similar to the neuronal t-SNARE syntaxin1a 
and “non-syntaxin t-SNAREs” that have a different architecture. Syntaxin t-SNAREs 
contain a short N-terminal peptide and a large auto-inhibitory “Habc domain” N-terminal 
to the SNARE motif. In some syntaxin t-SNAREs, this domain can bind the SNARE 
motif, forming a “closed” conformation and inhibiting formation of the SNARE complex 
30,32,37,40. For SNARE complex assembly to occur, the Habc domain must be released from 
the SNARE motif, which then interacts with two more t-SNARE motifs, before forming a 
fusion-competent SNARE complex with the v-SNARE motif (Figure 1.3). In some 
systems, the association between the Habc domain and SNARE motif is weak or almost 
non-existent, while in others the association is very tight. For example, in S. cerivisiae 
exocytosis to the plasma membrane the syntaxin t-SNARE Sso1p has such a tight 
association between the Habc domain and SNARE motif that formation of SNARE 
complex in vitro happens on a scale of days 41,42!  An “opener” protein has been 
hypothesized to encourage Sso1p to transition from the closed to open state. Our lab is 
currently screening for this protein. 
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Figure 1.3 Schematic representation of formation of the fusion-competent SNARE 
complex. Syntaxin t-SNAREs may have an autoinhibited closed conformation. Sso1p has 
a closed conformation which provides the rate limiting step in SNARE complex 
formation in vivo. An “opener” protein has been hypothesized to facilitate transition of 
Sso1p from the closed to open conformation. 
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Though SNAREs are presumed to be sufficient on their own for specificity and fusion 43-
45, two problems follow. First, SNARE proteins are not always localized, but may instead 
distribute across the entire surface of the membrane they occupy 46,47 and some SNAREs, 
such as Vti1p, are required for multiple trafficking steps 48. Thus, even if SNARE 
proteins could ensure fidelity on their own, they cannot localize fusion to the narrow 
regions required for proper secretion in diverse systems including from bud formation in 
S. cerevisiae and neurite outgrowth and synaptic release in higher eukaryotes. Secondly, 
while in vivo SNARE complexes appear to maintain high fidelity, in vitro, SNAREs can 
be promiscuous in their interactions 28,40,49-51. There are multiple examples of SNARE 
promiscuity  28,33,49-52. In the context of the cell, allowing this broad localization and 
possible promiscuity of fusion would result in severely misdirected cargo. Prevention of 
misdirection requires another layer of regulatory proteins. 
Tethering Factors 
When the trafficking vesicle arrives at the target organelle, tethering factors are 
there to form a bridge between vesicle and membrane, thus providing another layer of 
spatial regulation (Figure 1.1 red protein/complex). Tethering factors may traffic with the 
vesicle or be present prior to arrival. Tethering is defined as a reversible association with 
the target membrane and vesicle, stabilized by these factors, prior to docking and fusion 
5,53,54. Tethering proteins can be divided into two classes, the coiled-coils and the large 
multi-subunit complexes 55. This thesis will deal primarily with the exocyst, which is a 
member of the large multi-subunit tethering complexes, which include the COG 
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(conserved oligomeric Golgi), Dsl1p, GARP (Golgi-associated retrograde protein), 
HOPS (homotypic fusion and vacuole protein sorting), CORVET (class C core 
vacuole/endosome tethering), and TRAPP (transport protein particle) complexes.  
Despite a conserved function, tethering factors have very low sequence identity, 
less than 10% in most cases 55-57. However, some structural similarity is becoming 
apparent. First, there is identical bundle topology between the subunits of the exocyst and 
COG complex, and, evident more recently, between subunits of the exocyst, subunits of 
the Dsl1p complex, Myo2p, and recently limited domain homology with Munc13 53,56,58-60. 
A logical explanation for this overall similarity is divergent evolution. This involves 
duplication and modification of relevant genes along the trafficking pathway as new 
organelles evolved. It remains to be tested if these structural similarities will bear out as 
predictors of subunit function. This thesis is primarily concerned with the final step of 
exocytosis, trafficking from the Golgi apparatus to the plasma membrane. The tethering 
factor for this process is known as the exocyst and will be discussed in more detail later. 
 Further, these large oligomeric complexes have multiple roles beyond simply 
connecting the target membrane and vesicle. One role coming to light in recent years is 
the direct regulation of docking and fusion, steps of trafficking after tethering. In these 
steps, SNARE proteins form a fusion-competent SNARE complex and fusion of the 
membranes occurs. For example, the HOPS complex, involved in trafficking between the 
vacuole and endosomes, interacts directly with cognate SNARE proteins to “proofread” 
them and ensure fidelity by restricting the formation of SNARE complexes to those 
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between appropriate partners 61. In keeping with their conservation of function, but not of 
sequence, other complexes appear to have similar roles via different mechanisms. The 
GARP complex, involved in retrograde Golgi trafficking, interacts with one of the 
associated SNARE proteins, Tlg1p to encourage SNARE complex formation 62. 
Similarly, the COG complex, involved in Golgi trafficking, interacts with the SNARE 
protein Sed5p to stabilize the formation of SNARE complexes 63. Also similarly, the Dsl1 
complex interacts with the SNARE protein Use1p to stabilize formation of a SNARE 
complex 64. Finally, the exocyst has been shown to interact with the SNARE protein 
Sec9p in vitro 65. This suggests that the exocyst is a member of the growing majority of 
large tethering complexes that interact with and regulate SNARE complex assembly. 
Though the exact mechanisms of these interactions are poorly understood, the similarity 
in their function is undeniable and strengthens the suggestion that the large oligomeric 
tethering complexes are indeed products of evolutionary divergence.  
 
Sec1/Munc18 Proteins 
SM (Sec1/Munc18) proteins form yet another layer of regulation via interactions 
directly with SNAREs and often with tethering complexes as well (Figure 1.1 yellow 
protein) 53,66-68. Although the SM proteins show significant structural and sequence 
similarity, the elucidation of these interactions has been confusing and often contentious 
8,53,67,66. SM proteins appear to utilize diverse modes of binding to their cognate SNAREs, 
SNARE pairs, and SNARE complexes. SM proteins have even been shown to have both 
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stimulatory and inhibitory effects on SNARE complex assembly and fusion 53,66. 
Recently, however, much of the prior confusion was revealed to be artifactual due to 
insufficiently quantitative methodologies, and a more unifying mode of binding is 
emerging 69. SM proteins appear to bind primarily via two binding pockets, a small 
hydrophobic pocket which interacts with the N-terminal peptide of the syntaxin and a 
larger pocket that wraps around and binds the autoinhibited form of the target syntaxin t-
SNARE 53,68,67,69.  
Sec1p, the SM protein most relevant to this thesis appears to have a slightly 
different interaction mode than other SM proteins. First, there is no interaction between 
Sec1p and its cognate syntaxin t-SNARE, Sso1p 70. Second, an interaction occurs 
between Sec1p and the complete ternary SNARE complex 70,71. This interaction likely 
uses the same cleft that in other SM proteins binds the closed conformation of the 
syntaxin t-SNARE 72. Finally, Sec1p has recently been implicated activities prior to 
regulation of SNARE complex formation 72. 
 
Proteins Essential for Plasma Membrane Exocytosis 
The Exocyst 
The exocyst is a member of the large multi-subunit complex family of tethering 
factors, which also includes the COG, Dsl1p, GARP, HOPS, CORVET, and TRAPP 
complexes 53,58,73-76. These factors all contain multiple subunits, assembled into a large 
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oligomeric complex. They have been proposed to interact reversibly with the plasma and 
vesicle membranes through small Rab and Rho GTPases that function as spatial 
landmarks before docking 22. However, there is recent evidence that the GTPase role in 
tethering may be more complex than previously thought. Beyond acting as timers to 
associate tethering factors with membranes, GTPases may interact with proteins and even 
with the membrane itself to directly regulate docking, fusion, and membrane deformation 
21,77.  
The exocyst is the oligomeric tethering complex essential for Golgi to plasma 
membrane anterograde trafficking 78. The complex is comprised of one copy each of eight 
subunits: Sec3p, Sec5p, Sec6p, Sec8p, Sec10p, Sec15p, Exo70p, and Exo84p and 
interacts with small GTPases on the vesicle and plasma membranes (Figure 1.4). The 
exocyst is conserved in all eukaryotes 5,53. The “Y” shape of the exocyst in the schematic 
diagram derives from a similar shape displayed in high resolution rapid-freeze deep-etch 
EM (Electron Microscopy) images of purified bovine brain exocyst complexes fixed with 
glutaraldehyde 79. Complexes that have not been fixed in glutaraldehyde appear to 
“bloom” into multi-armed flower shapes. It remains unclear if these structures represent 
in vivo structures or not. 
The exocyst subunits, except Exo70p and Exo84p, were originally identified in a 
yeast mutational screen for yeast with defective secretion 15. The complex was found to 
localize to active sites of polarized secretion 5,22,23,78,80. This temporal and spatial location 
positions the exocyst appropriately to be an important regulatory factor in exocytosis to  
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Figure 1.4 The exocyst complex interacts with the vesicle and plasma membranes to 
tether before docking. The eight-subunit exocyst interacts with the small GTPase Sec4p 
on the vesicle membrane via Sec15p. Interaction with the plasma membrane occurs via 
an unidentified “anchor” interacting with Sec6p to localize the exocyst, and with the 
small GTPases Rho1p, Rho3p, and Cdc42p interacting with Sec3p and Exo70p.  
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the plasma membrane. The exocyst is proposed to be the tether for Golgi-plasma 
membrane trafficking because of interactions with Sec4p on the vesicle and Cdc42p, 
Rho3p, and Rho1p on the plasma membrane 81-86. However, it has recently been shown 
that these GTPases are not, in fact, sufficient for maintaining localization of the exocyst. 
Instead, the exocyst remains spatially localized via an interaction between the Sec6p 
subunit and an as-yet unidentified anchor protein 87. Though the exocyst is considered a 
vesicle tether, the “tethering” function of the exocyst has yet to be directly demonstrated. 
Several subunits of the exocyst or portions thereof have been crystallized, 
showing a conserved helical bundle structure 5,59,88,89. Currently there are crystal structures 
for full-length Exo70p from yeast, mice, and humans 90-92, and C-terminal regions of yeast 
Sec6p 88 and Exo84p90, and Drosophila Sec15p 93. These structures display a startling 
similarity. The helical bundle topology of all these proteins is identical, suprising 
considering the lack of sequence identity. This conserved architecture has also been 
observed in other members of the exocyst and subunits of other large oligomeric 
tethering complexes as well as, non-tethering, proteins. Dsl1p, Cog4p, Myo2p, Myo4p, 
Sec6p, Exo70p, Exo84p, Sec15p, Tip20, and Cog2p all show an identical bundle 
topology and similar overall architecture by crystal structure analysis, and Sec10p 
displays a similar structure by threading algorithms 5,59,89,88. These results suggest a 
similar origin, if not mechanism of function, possibly via the structurally similar “E 
domains” (named for the relevant domain of the Cog4p subunit) suggested by Richardson 
et. al 59. Like the oligomeric complexes as a whole, this structural similarity suggests that 
a gene duplication followed by divergent evolution, was responsible for the current 
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exocyst consisting of eight proteins with remarkably similar structure, though little 
sequence identity. Unfortunately, the new wealth of structural information has not yet led 
to a directly corresponding increase in knowledge about the function of the exocyst as a 
whole or of subunits individually. New research must connect the structural information 
to functional knowledge of exocyst subunits and possibly to subunits of other complexes. 
Though functional information is not complete, neither is it absent. We know, for 
instance, that all of the exocyst subunits are essential, though sec3Δ strains are capable of 
growing very slowly on minimal media 83. Temperature-sensitive mutants of most strains 
cease growth or die 15,5. This makes further analysis often difficult. Disruption of the 
secretory pathway often causes phenotypes that don’t allow direct identification of the 
disrupted mechanism, such as a backup of unfused vesicles at sites of secretion 15. 
However, some insight has been acquired via the temperature-sensitive mutants, as 
localization and interactions can be examined concurrently with exocytic failure. 
Subunits of the Exocyst 
The subunits of the exocyst play multiple roles both within and external to the 
complex. Elucidation of the interactions and functions of the exocyst subunits is 
challenging, however, recent in vivo and in vitro data has moved the field forward. In 
addition to intra-exocyst interactions, the exocyst interacts with both the vesicle and 
plasma-membrane via small Rab and Rho GTPases. Exocyst-vesicle interaction is 
mediated by the exocyst subunit Sec15p via the small Rab GTPase Sec4p on the vesicle 
membrane 23,94. On the plasma-membrane, Sec3p, through interactions with the small 
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GTPases Cdc42 and Rho1 (Figure 1.5 a), was proposed to be the primary localizing force 
for the exocyst 82-84. However, certain GFP tags on Sec3p are sufficient for stabilizing 
localization when it would otherwise be disrupted 87,95, though this result has been 
disputed 96. Similarly, Exo70p may be a second spatial landmark for the exocyst, as it 
interacts with both the small GTPase Rho3p (Figure 1.5 b)81 and with 
phosphatidylinositol 4,5-bisphosphate 97. In one model of exocyst assembly wherein most 
subunits are trafficked with the vesicle, Exo70p and Sec3p are already present and 
localized at the plasma membrane presumably via interactions with their small Rho 
GTPases 98. In mammals, Sec5 has an additional GTPase binding domain which interacts 
with RalA and RalB to aid in exocyst targeting via paxillin during cell migration 99,100. 
Interestingly, Sec5-RalA/B interactions are implicated in oncogenesis and immunity 
responses via interaction with TBK1 101,102. 
Internal exocyst contacts are multitudinous, though far from completely described 
(Figure 1.5). Beginning from the vesicle, Sec15p is linked to the exocyst by interactions 
with the subunit Sec10p 94 (Figure 1.5 (c)) with which Sec15p forms a subcomplex, 
though the function of this subcomplex is unknown 23. Sec10p in turn interacts with 
Sec6p 89,88, with Exo70p 90, with Sec5p and possibly Exo84p 103 (Figure 1.5 d, e, f, g). 
Sec6p interacts with Sec8p 88, as well as Sec5p (Figure 1.5 h,i), but Sec6p shows no 
interactions via a yeast two-hybrid assay 103. The C-terminal domain of Sec6p is sufficient 
for interaction with Exo70p though not for Sec8p interaction 88. Exo70p completes a loop, 
interacting with Sec5p (Figure 1.5 j)103.  Sec5p interacts with Exo84p, Sec8p, and Sec3p 
(Figure 1.5 k, l, m) 103. Finally, Sec3p may interact with Sec8p (Figure 1.5 n) 23. 
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Figure 1.5 Schematic of intra and extra exocyst interactions. Interactions between 
yeast exocyst components (colored, numbered proteins) have been mapped schematically 
as well as external interactions with known non-exocyst proteins (grey ovals). (As 
referenced in 5) 
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Additionally, in the mammalian exocyst, interactions have been shown by yeast two-
hybrid between Exo70, Exo84, and Sec15 104. 
Subunits of the exocyst are not limited to interactions within the complex and 
with small GTPases. Many subunits are also involved in interactions with non-exocyst 
proteins. For example, Sec15 interacts with the polarity-determinant protein Bem1p 105,106 
and Sec2p, the exchange factor for Sec4p 107. Similarly, Sec10p is involved in hormone 
Drosophila oocyte 108. Additionally in Drosophila, trafficking of the protein DE-Cadherin 
appears to be controlled by a subset of the exocyst including Sec5, Sec6, and Sec15 109. 
Exo84 is required for the foundation of apical identity of epithelial cells, via its direct 
interaction with the transmembrane protein Crumbs 110. Exo84p also directly interacts 
with Sro7p and Sro77p which may play a role in the establishment of cell polarity and 
may interact with Sec9p 111.  
The bulk of this thesis focuses on the role of Sec6p, and its involvement with two 
associated non-exocyst proteins. The C-terminal region of Sec6p has been crystallized, 
showing a conserved helical bundle fold, similar to other members of the exocyst and 
other tethering complex subunits (Figure 1.6) 5,59,89,88. Additionally, some limited 
homology has been discovered between Sec6p and portions of Munc13p, which interacts 
with SNARE proteins 60. Conserved residues in this C-terminal region have recently been 
shown to be essential for the maintenance of exocyst localization at sites of secretion via 
a proposed anchor protein 87. These residues are required for localization even when wild-
type Sec3p and Exo70p remain in the complex. This suggests that, while Exo70p and  
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Figure 1.6 The conserved architecture of the C-terminal region of Sec6p. The C-
terminal region of S. cerevisiae Sec6p (pdb 2FJI), shows a conserved fold similar to 
portions of D. melanogaster Sec15 (pdb 2A2F), S. cerevisiae Exo84p (pdb 2D2S), S. 
cerevisiae Exo70p (pdb 2PFV), S. cerevisiae Cog2p (pdb 2JQQ), H. sapiens Cog4 (pdb 
3HRO), S. cerevisiae Tip20p (pdb 3FHN), S. cerevisiae Dsl1p (pdb 3ETU), and S. 
cerevisiae Myo2p (pdb 2FH). Visualized using Pymol (pymol.org) 
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Sec3p may be required for initial localization, they are insufficient for its maintenance. 
Whether the exocyst can be localized via Sec6p-Anchor interaction in the absence of 
Exo70p and Sec3p interaction with their GTPases remains untested. The N-terminal 
region of Sec6p remained largely unexamined until this thesis, as it has been resistant to 
in vitro purification techniques and deletion analysis.  
Sec6p tightly dimerizes in vitro, such that no monomer can be detected even at 
very low concentrations of Sec6p 65. Though the existence of the dimer has not yet been 
successfully demonstrated in vivo, a “free pool” of Sec6p, dissociated from the exocyst, 
clearly exists in the cytosol of yeast. This free pool migrates similarly to purified dimer 
on gel filtration columns, suggesting that the free pool of Sec6p exists as a dimer in the 
cell 65. 
Though Sec6p interacts with the t-SNARE Sec9p in vitro, the C-terminal region is 
not sufficient for that interaction 65. I hypothesized that the interaction between Sec6p and 
Sec9p might relieve auto-inhibition of the syntaxin t-SNARE Sso1p, however, addition 
of purified Sec6p in vitro imposed a further threefold inhibition on formation of the 
binary t-SNARE complex between Sec9p and Sso1p. This suggests that in vivo another 
factor is present and the apparent slowing represents trapping of an intermediate bound 
state 65. 
Exocytic SNAREs: Sec9p, Sso1p, Snc2p 
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 The exocytic SNARE proteins are the v-SNARE Snc2p, the non-syntaxin t-
SNARE Sec9p, and the syntaxin t-SNARE Sso1p 15,46,112-114. Deletions of either SSO1 or 
its homolog SSO2 have no notable phenotype during normal growth, though there is 
evidence of sporulation-specific function of Sso1p 41,115,116. The Ha, Hb, and 3’ UTR 
(untranslated region) of Sso1p are required for proper sporulation 116,117. Because Sso1p 
and Sso2p are functionally identical during the growth dealt with in my experiments, I 
will discuss only Sso1p in depth in this thesis.  
 Snc2p is an 115 amino acid v-SNARE homologous to synaptobrevin utilized for 
exocytosis to the plasma membrane with a homologous protein Snc1p with overlapping 
but not identical function 118,119. For the aspects of fusion discussed in this thesis, Snc1p 
and Snc2p may be considered equivalent. Snc2p is anchored in the vesicle membrane by 
a transmembrane domain 119.  
Sec9p is a 659 amino acid t-SNARE, with two SNARE motifs connected by a 
long linker 15,46. When in the SNARE complex, these motifs are parallel, with the linker 
spanning the distance between them. However, when Sec9p is not in complex, it remains 
largely unstructured 27,42. When in a heterodimeric binary t-SNARE complex with Sso1p, 
one Sec9p SNARE motif remains largely structured, and the other alternates between a 
structured and unstructured state 120. Unlike most SNAREs, Sec9p has no transmembrane 
domain, and any post-translational modification that could anchor the protein to the 
membrane has not yet been identified 46. Additionally, Sec9p has a large N-terminal 
region that appears to be non-essential in the lab environment. Deletion of this N-terminal 
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region has no effect on cells, and the function of this region remains unknown 46. 
Additionally, Sec9p has been shown to interact with Sec6p in vitro 65. As mentioned 
above, Sec9p forms a heterodimeric binary t-SNARE complex with its t-SNARE partner, 
Sso1p. 
Sso1p is a prototypical syntaxin t-SNARE, with a transmembrane domain, 
SNARE motif, linker, and Habc domain. Though the short N-terminal peptide of Sso1p is 
truncated and not well conserved 112,115,121. Unlike some other syntaxin t-SNAREs, the 
autoinhibition of the Habc:SNARE motif interaction is strong in Sso1p 
42,115. This 
interaction is so tight in vitro that the dissociation of the Habc domain and formation of a 
binary t-SNARE complex between Sec9p and Sso1p/Sso2p requires forty-eight hours 
65,112,115! This tight association that prevents formation of the SNARE complex provides 
another source of regulation, as it prevents promiscuous SNARE pairing. However, the 
association is so tight that an “opener” protein, or proteins, appears to be required to 
facilitate dissociation of the Habc domain and formation of the binary t-SNARE complex 
on a biological timescale 115. Once the binary t-SNARE complex has been formed, in 
vitro, the ternary fusion-competent SNARE complex can form rapidly 41,42,115. 
Sec1p 
 Sec1p is the SM protein essential for exocytosis to the plasma membrane 71. Sec1 
is the founding member of the SM proteins, though it surprisingly remains a poorly 
understood member of the family. Sec1p is one of the SM proteins that causes the most 
controversy among researchers, as its binding modes with cognate SNARES differ most 
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from others in the family. Unlike most other SM proteins, Sec1p interacts with the 
complete ternary SNARE complex to regulate fusion with the plasma membrane 71, rather 
than with the N-terminal peptide or closed, autoinhibited form of its syntaxin Sso1p 
53,68,66,67. However, like other SM proteins, Sec1p interacts with its associate tethering 
complex, the exocyst, albeit weakly 122. The crystallized squid neuronal nSec1 displays a 
common architecture shared by SM proteins 123. Three domains are organized in a 
horseshoe shape around a large central binding pocket. Additionally, there is a small N-
terminal hydrophobic binding pocket, which in some SM proteins interacts with the N-
terminal peptide of the syntaxin t-SNARE 53,68,66,67,69,124. 
 
The State of the Field 
Many questions currently loom both large and small in the field of trafficking in 
general, and the exocyst specifically. Among those questions: what is the purpose of a 
large, eight protein, tethering complex that is almost a megadalton in size? And why is 
the exocyst a complex? What are the collective and individual functions of the subunits? 
Why do the eight proteins have such similar architecture? Does the existence of a 
complex suggest that these proteins function both as free and oligomeric forms? Does the 
similarity of exocyst subunits to the proteins of other tethering complexes such as Dsl1p, 
Cog4, etc. suggest a conserved evolutionary mechanism that evolved along with the 
compartments they serve? If so, what can the study of individual protein function allow 
us to predict about the function of other similarly folded proteins? Clearly, the functions 
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cannot be identical or all of the C-termini of the exocyst proteins would be doing the 
same thing; and there is enough divergence in interaction to show that this is clearly not 
the case. This would not be the first example of similarly structured subunits with 
differing functions. The proteosome provides another example of a complex likely arising 
from gene duplication with divergence of function between subunits 125,126.  
And there are questions still more specific: Many of the uncrystallized N-termini 
remain largely unstudied, as was the N-terminal region of Sec6p until this thesis, due to 
difficulties with purification and aggregation. Are they resistant to purification for a 
common reason? Perhaps the difficulties indicate lengthy binding regions, buried in the 
core of the complex, leaving the C-termini to give rise to the mysterious flower-shaped 
structure revealed by the EM images 79.  
And finally, on the largest, and most grandiose, scale: What can we learn about 
the origins of ourselves, of all eukaryotes, from this system? The elements of trafficking 
are clearly linked with common structures and common mechanisms separated by 
apparently small details that nonetheless maintain the system’s fidelity, maintaining 
crucial life processes. What might understanding a system this ubiquitous to life reveal? 
In the practical realm, our understanding of trafficking as a whole is comparatively 
pitiful, but in recent years it is experiencing a dawning renaissance as small discoveries 
snowball into further, larger discoveries and conclusions. The field appears perched on a 
cusp of understanding, as if a few more small insights might push our collective 
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knowledge over a metaphorical barrier range and into a whole new realm of biological 
wisdom. 
This sudden expansion of knowledge has vast potential in the medical realm for 
understanding a host of ailments. Everything, from the placement of receptors and 
channels on the surface of neurons to the absorption of nutrients in the stomach, is 
controlled by these proteins and processes 11-13,53,54,127. The exocyst, for example, appears 
to be essential for the formation of functional epithelial apical membranes, which absorb 
nutrients, for tight junctions, which keep stomach contents in the stomach, and for growth 
of the neurites and dendrites, which make your brain function as a brain rather than a 
dissociated set of spherical cells, indeed the exocyst is required as early as the first 
divisions of oocyte cells 53,128,129,132,133,130,131. Complete knowledge of these proteins and 
pathways could have an incalculable impact on both our understanding of and future 
treatment of our bodies.  
On a far less grandiose, and more realistic, scale are the questions that might be 
answered by the study of one protein, the questions which strive to push the field over 
that long-sought rise. This thesis strives to answer that level of question about one such 
protein – Sec6p. There remains much to be discovered about the function of the exocyst 
and its subunits, and much that might be generalized to other trafficking pathways.  
Most of the research on Sec6p, and indeed on many oligomeric complex subunits, 
including Exo84p, Cog2, and Sec15p has been performed on the C-terminal region due to 
that portion’s comparative tractability 59,65,79,87,89,88,90,93,134. Exo70p, for which the full 
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protein has been crystallized, displays a similar N-terminal architecture to the conserved 
fold of the C-terminal region of Sec6p 5,59,89-91. However the C-terminal region of Sec6p is 
not sufficient for function in the cell 88; so what is the function of the N-terminal region? 
Our lab demonstrated that the C-terminal region is insufficient for binding of Sec9 65. 
Why might Sec6p bind to Sec9p? in vitro SNARE assembly assays  suggest that Sec6p is 
inhibiting SNARE complex assembly by more than threefold 65. Could this apparent 
inhibition actually be capturing an intermediate binding state? Is Sec6p supposed to 
“hand off” Sec9p to another accessory protein in vivo that then enhances the formation of 
the binary t-SNARE complex? What protein might this be? Sro7p has also been shown to 
inhibit SNARE complex assembly through an interaction with Sec9p 135, could that be the 
other regulatory factor? Could it be one of the other identified regulatory proteins? 
Perhaps one of the other exocyst subunits could be the missing factor? Could the SM 
protein, Sec1p, or one of the GTPases, or the putative anchor protein be involved? Or is 
there another, undiscovered, step to docking? Is there a reason that Sec6p might actually 
be inhibiting the formation of the binary complex?  
What other functions does the N-terminal region of Sec6p perform in vivo? What 
proteins does it interact with, and for what purpose? Does the N-terminal region form the 
core of the exocyst and interact with multiple subunits thus shielding the “sticky” tail 
from aggregation and non-specific interaction? What about the free pool of Sec6p that 
exists as dimers in the cytosol 65? Is the free pool a “storage tank” for Sec6p until it’s 
needed for exocyst assembly, or is there a separate function for Sec6p outside its function 
as an exocyst subunit? Does the function of Sec6p fit with the emerging trends in 
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trafficking biochemistry? These are the questions I hope to explore in this thesis, and to 
see answered in full by the field in years to come.
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Chapter II: 
 
Disruption of N-terminal exocyst binding residues in 
Sec6p results in a stable subcomplex  
localized to sites of exocytosis 
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ABSTRACT 
 Trafficking of protein and lipid cargo through the secretory pathway in eukaryotic 
cells is mediated by membrane-bound vesicles. Secretory vesicles are targeted to sites of 
exocytosis on the plasma membrane in part by a conserved multi-subunit protein complex 
termed the exocyst. In addition to tethering vesicles to the plasma membrane, the exocyst 
complex may directly regulate assembly of the SNARE complex, which is required for 
membrane fusion. Here we show that an interaction between the plasma membrane t-
SNARE Sec9p and the yeast exocyst subunit Sec6p can be observed in vivo. Point 
mutations in the N-terminal domain of Sec6p result in temperature sensitive growth and 
secretion defects, without loss of Sec6p-Sec9p interaction. At the non-permissive 
temperature, the exocyst subunits Sec5p, Sec10p and Sec15p are mislocalized and are 
absent from the exocyst complex. The resulting subcomplex, containing Sec6p, Sec3p, 
Sec8p, Exo70p and Exo84p, remains stably assembled and localized at sites of polarized 
secretion. Additionally, one of the sec6 temperature sensitive mutants displays a loss of 
binding to the yeast regulatory protein Sec1p. In vitro binding studies indicate a direct 
interaction between Sec1p and the wild-type Sec6p protein, suggesting close interplay 
between Sec6p and Sec1p in the regulation of SNARE complexes.  
54 
 
INTRODUCTION 
 Exocytosis in eukaryotes requires the proper trafficking of membrane bound 
vesicles between functionally and chemically distinct organelles and the plasma 
membrane for growth, secretion, and proper cellular functioning. Trafficking is a 
conserved and highly regulated process, utilizing multiple classes of essential proteins to 
ensure that cargo is properly delivered both spatially and temporally 8 (and references 
therein). SNARE proteins on the target membrane (t-SNAREs) and vesicle (v-SNAREs) 
interact to form a four-helix-bundle, termed the SNARE complex, which bridges the 
vesicle and plasma membrane for fusion. The formation of fusion competent SNARE 
complexes is regulated by a number of proteins, including tethering factors such as the 
exocyst and the Sec1/Munc18 (SM) proteins 67. 
 Prior to SNARE complex assembly, vesicles are hypothesized to be held in a 
reversible association with the target membrane, a process termed tethering. Tethering is 
thought to be facilitated by long coiled-coil proteins and large protein complexes, 
including the exocyst, COG (conserved oligomeric Golgi), Dsl1p, GARP (Golgi-
associated retrograde protein), HOPS (homotypic fusion and vacuole protein sorting) and 
TRAPP (transport protein particle) complexes 53,58,73,74. Tethering factors have been 
proposed to interact with the target and vesicle membranes via small GTPases of the Ras 
superfamily 22, although recent data suggests that the role of the GTPases may be 
primarily regulatory 22,77, and membrane anchoring may be achieved through interactions 
with other proteins 87.   
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 In addition to membrane tethering, multi-subunit complexes such as the exocyst 
may directly regulate membrane fusion through interaction with the SNARE fusion 
machinery. For example, a recent study revealed that the HOPS complex interacts with 
the vacuolar trans-SNARE complex in yeast to confer specificity 61. Similarly, the COG, 
Dsl1p, and GARP complexes bind to individual SNAREs or SNARE complexes 62-64. The 
exocyst is also implicated in SNARE regulation. We previously demonstrated that 
recombinant Sec6p, an exocyst subunit, interacts with the yeast plasma membrane t-
SNARE Sec9p in vitro; in the absence of other factors, Sec6p inhibits the interaction 
between Sec9p and its SNARE partners 65.  
 The regulation of SNARE proteins and SNARE complex formation may also be 
carried out in conjunction with the Sec1/Munc18 (SM) protein family. The SM proteins 
interact with both individual SNARE proteins and SNARE complexes, making their 
function(s) challenging to elucidate, as SM proteins appear to bind their cognate 
SNAREs through several distinct modes of interaction (for review see 66,136). Several of 
the SM proteins have also been shown to interact with tethering complexes. The 
interaction between the ER to Golgi SM protein Sly1p and the COG complex is required 
for SNARE complex assembly 137, while the HOPS complex includes the vacuolar SM 
protein Vps33p among its subunits 73. Similarly, the yeast exocytic SM protein Sec1p 
interacts with the exocyst complex 122. Currently, the precise functions of these 
interactions are unclear.  
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 The exocyst is a large oligomeric complex implicated in tethering secretory vesicles 
to the plasma membrane. The exocyst is structurally and functionally related to the large 
multi-protein tethering complexes COG, Dsl1p, and GARP 53,58,59,138-140. It is conserved in 
all eukaryotes and is essential for growth and secretion 5,22,23,78,141, playing essential roles 
in exocytosis, endocytosis, and cytokinesis 108,130,142,143. The exocyst is composed of eight 
subunits:  Sec3p, Sec5p, Sec6p, Sec8p, Sec10p, Sec15p, Exo70p, and Exo84p. Four 
subunits contain conserved rod-like structures composed of multiple helical bundles 
while the rest are predicted to contain similar structures 53,58,59,88-93. The exocyst subunits 
are localized to sites of polarized growth and secretion in various eukaryotic cell types 
78,144,145.  
 Regulation of exocyst localization was thought to be facilitated by Sec3p and 
Exo70p via their interactions with the small GTPases Rho1p, Rho3p and Cdc42p, and 
with phosphatidylinositol 4,5-bisphosphate 81,85,86,96,97. However, localization of the 
exocyst by Sec3p remains controversial, as Roumanie et al. have suggested some GFP 
tags on Sec3p may artificially stabilize its interaction with the plasma membrane 95. Also, 
the exocyst localizes in the absence of the Rho3p-Exo70p interaction 95, although these 
results have been disputed 96. Additionally, we recently demonstrated that residues in the 
C-terminal domain of Sec6p are essential for maintenance of the exocyst complex at sites 
of secretion via interactions with a putative anchor protein 87.  
 Because previous studies demonstrated interactions between Sec6p and the SNARE 
Sec9p 65, between the exocyst and Sec1p 122, and between Sec1p and the SNARE 
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complex 70, we were interested in examining the functional relationships between these 
proteins in vivo. We used coimmunoprecipitation experiments to show that Sec6p and 
Sec9p interact in yeast. These coimmunoprecipitations also revealed that the interaction 
involves a previously identified non-exocyst-bound “free” pool of Sec6p 65. Mutation of 
residues in the N-terminal region of Sec6p do not affect this interaction, rather, they 
destabilize intramolecular exocyst contacts responsible for exocyst assembly and/or 
stability. In the sec6 mutants, the exocyst subunits Sec5p, Sec10p, and Sec15p dissociate 
from the complex and mislocalize at the restrictive temperature. The remaining subunits 
(Sec6p, Sec8p, Sec3p, Exo70p, and Exo84p) comprise a stable subcomplex localized to 
sites of secretion. Furthermore, one of the sec6 mutants disrupts a direct interaction with 
Sec1p, suggesting a fundamental link between the exocyst and Sec1p in the regulation of 
SNARE-mediated exocytosis. 
 
MATERIALS AND METHODS: 
Yeast methods 
 Mutations (sec6-43: R153D, sec6-44: D154R, sec6-46: Q156K/E157K/Q158K) 
were introduced by PCR into the SEC6 gene in the BamHI and NotI sites of yeast 
plasmid pRS315 (LEU2 CEN) including the endogenous regulatory regions of SEC6 (0.5 
kb of flanking genomic sequences at the 5’ and 3’ ends), and the presence or absence of a 
C-terminal triple hemagglutinin (HA3) tag for immunofluorescence and 
immunoprecipitation studies (Table 2.1). All mutations were confirmed by sequencing.  
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Table 2.1. Yeast strains used in this study 
Strain Relevant genotype 
MMY251 MATα sec6Δ::KanMX-4 his3∆1 leu2∆0 ura3∆0  (LEU2 CEN SEC6) 
MMY404 MATα sec6Δ::KanMX-4 his3∆1 leu2∆0 ura3∆0  (LEU2 CEN sec6-43) 
MMY405 MATα sec6Δ::KanMX-4 his3∆1 leu2∆0 ura3∆0  (LEU2 CEN sec6-44) 
MMY406 MATα sec6Δ::KanMX-4 his3∆1 leu2∆0 ura3∆0  (LEU2 CEN sec6-46) 
NY778 MATα leu2-3,112 ura3-52 sec6-4 (Novick et al., 1980) 
MMY275 MATα sec6Δ::KanMX-4 his3∆1 leu2∆0 ura3∆0  (LEU2 CEN SEC6-HA3) 
MMY582 MATα sec6Δ::KanMX-4 his3∆1 leu2∆0 ura3∆0  (LEU2 CEN sec6-44-HA3) 
MMY583 MATα sec6Δ::KanMX-4 his3∆1 leu2∆0 ura3∆0  (LEU2 CEN sec6-56-HA3) 
MMY204 MATα sec6Δ::KanMX-4 his3∆1 leu2∆0 ura3∆0 (URA3 CEN SEC6) 
MMY246 MATa  sec6Δ::KanMX-4 his3∆1 leu2∆ 0 met15∆0 ura3∆0 Sec3-GFP(HIS3) (URA3 CEN SEC6) 
MMY238 MATa  sec6Δ::KanMX-4 his3∆1 leu2∆ 0 met15∆0 ura3∆0 Sec5-GFP(HIS3) (URA3 CEN SEC6) 
MMY239 MATa  sec6Δ::KanMX-4 his3∆1 leu2∆ 0 met15∆0 ura3∆0 Sec8-GFP(HIS3) (URA3 CEN SEC6) 
MMY247 MATa  sec6Δ::KanMX-4 his3∆1 leu2∆ 0 met15∆0 ura3∆0 Sec10-GFP(HIS3) (URA3 CEN SEC6) 
MMY248 MATa  sec6Δ::KanMX-4 his3∆1 leu2∆ 0 met15∆0 ura3∆0 Sec15-GFP(HIS3) (URA3 CEN SEC6) 
MMY249 MATa  sec6Δ::KanMX-4 his3∆1 leu2∆ 0 met15∆0 ura3∆0 Exo70-GFP(HIS3) (URA3 CEN SEC6) 
MMY250 MATa  sec6Δ::KanMX-4 his3∆1 leu2∆ 0 met15∆0 ura3∆0 Exo84-GFP(HIS3) (URA3 CEN SEC6) 
MMY532 MATa  sec6Δ::KanMX-4 his3∆1 leu2∆ 0 met15∆0 ura3∆0 Sec3-GFP(HIS3) (URA3 CEN sec6-44) 
MMY534 MATa  sec6Δ::KanMX-4 his3∆1 leu2∆ 0 met15∆0 ura3∆0 Sec5-GFP(HIS3) (URA3 CEN sec6-44) 
MMY537 MATa  sec6Δ::KanMX-4 his3∆1 leu2∆ 0 met15∆0 ura3∆0 Sec8-GFP(HIS3) (URA3 CEN sec6-44) 
MMY540 MATa  sec6Δ::KanMX-4 his3∆1 leu2∆ 0 met15∆0 ura3∆0 Sec10-GFP(HIS3) (URA3 CEN sec6-44) 
MMY543 MATa  sec6Δ::KanMX-4 his3∆1 leu2∆ 0 met15∆0 ura3∆0 Sec15-GFP(HIS3) (URA3 CEN sec6-44) 
MMY546 MATa  sec6Δ::KanMX-4 his3∆1 leu2∆ 0 met15∆0 ura3∆0 Exo70-GFP(HIS3) (URA3 CEN sec6-44) 
MMY549 MATa  sec6Δ::KanMX-4 his3∆1 leu2∆ 0 met15∆0 ura3∆0 Exo84-GFP(HIS3) (URA3 CEN sec6-44) 
MMY532 MATa  sec6Δ::KanMX-4 his3∆1 leu2∆ 0 met15∆0 ura3∆0 Sec3-GFP(HIS3) (URA3 CEN sec6-56) 
MMY535 MATa  sec6Δ::KanMX-4 his3∆1 leu2∆ 0 met15∆0 ura3∆0 Sec5-GFP(HIS3) (URA3 CEN sec6-56) 
MMY538 MATa  sec6Δ::KanMX-4 his3∆1 leu2∆ 0 met15∆0 ura3∆0 Sec8-GFP(HIS3) (URA3 CEN sec6-56) 
MMY541 MATa  sec6Δ::KanMX-4 his3∆1 leu2∆ 0 met15∆0 ura3∆0 Sec10-GFP(HIS3) (URA3 CEN sec6-56) 
MMY544 MATa  sec6Δ::KanMX-4 his3∆1 leu2∆ 0 met15∆0 ura3∆0 Sec15-GFP(HIS3) (URA3 CEN sec6-56) 
MMY547 MATa  sec6Δ::KanMX-4 his3∆1 leu2∆ 0 met15∆0 ura3∆0 Exo70-GFP(HIS3) (URA3 CEN sec6-56) 
MMY550 MATa  sec6Δ::KanMX-4 his3∆1 leu2∆ 0 met15∆0 ura3∆0 Exo84-GFP(HIS3) (URA3 CEN sec6-56) 
MMY441 MATa sec6Δ::KanMX-4 hisΔ1 leu2Δ0 ura3Δ0 SEC8-MYC3(URA3) (LEU2 CEN SEC6-HA3) 
MMY651 MATa sec6Δ::KanMX-4 hisΔ1 leu2Δ0 ura3Δ0 SEC8-MYC3(URA3) (LEU2 CEN sec6-44-HA3) 
MMY652 MATa sec6Δ::KanMX-4 hisΔ1 leu2Δ0 ura3Δ0 SEC8-MYC3(URA3) (LEU2 CEN sec6-56-HA3) 
MMY138 MATα his3∆1 leu2∆0 ura3∆0 SEC6-Myc13 (KANMX6) 
MMY584 MATα sec9Δ::KanMX-4 his3∆1 leu2∆0 ura3∆0 (URA3 CEN Sec9-HA3) 
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sec6 LEU2 CEN plasmids were introduced as the sole copy of SEC6 in yeast by 
transformation and plating on 5-FOA (5-fluoro-orotic acid) to select for loss of the wild-
type SEC6 URA3 CEN from MMY204 (Table 2.1). For green fluorescent protein (GFP) 
analyses, sec6 LEU2 CEN plasmids were introduced as the sole copy of SEC6 in yeast 
carrying individual genomic C-terminally GFP-tagged exocyst subunits (Table 2.1) by 
transformation and plating on 5-FOA to select against the wild-type SEC6 URA3 CEN. 
For serial dilution testing, strains containing wild-type or mutant sec6 were grown 
overnight to an O.D.600 of 1-2 and diluted to an O.D.600 of 1. Serial 1:10 dilutions were 
spotted onto SC (synthetic complete) and YPD media at various temperatures. Growth 
curves were acquired using strains containing wild-type or mutant sec6 grown overnight 
to an O.D.600 of ~1 and diluted to 0.1 O.D. As growth progressed, cultures were diluted to 
keep the O.D.600 below 1.0.  Media, growth conditions, and yeast genetic methods were 
as in 115. Yeast strains used in this study are listed in Table 2.1. Invertase secretion and 
Bgl2p secretion assays were performed as in 81.  
Indirect Immunofluorescence 
 Yeast strains containing either wild-type or mutant sec6 with a C-terminal HA3 tag 
were grown to log phase in YPD media at 25ºC and immediately fixed or shifted to 
nonpermissive conditions in YPD at 37ºC for 4h and fixed in 37% formaldehyde. Cells 
were permeabilized in HS/SDS buffer (0.1 M HEPES, pH 7.4, 1.0 M sorbitol, and 0.5% 
SDS), and washed twice in HS buffer. Cells were then placed on slides (Electron 
Microscopy Sciences, Fort Washington, PA) that had been prepared with 0.1% 
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polylysine. A 1:400 dilution of α-HA-Alexa Fluor 488 (Molecular Probes, Eugene, OR) 
conjugated antibody was added to visualize Sec6p-HA3. Differential interference contrast 
and fluorescence images were acquired at room temperature using an Axioskop2 plus 
epifluorescence microscope (Zeiss, Thornwood, NY) fitted with a 100X Plan-
NEOFLUAR (Zeiss 1.30 NA oil immersion) objective lens. Images were collected using 
a Diagnostic Instruments camera (Sterling Heights, MY, model 2.1.1) and 3
rd
 Party 
Interface Advanced (version 3.5.4 for MacOS) software. Immunofluorescence images 
were adjusted for total contrast in Adobe Photoshop (version 7.0.1, San Jose, CA). 
GFP Fluorescence 
 Yeast strains containing genomic C-terminally GFP-tagged exocyst subunits and 
wild-type SEC6 or mutant sec6 were grown to log phase in YPD media at 25ºC and 
shifted to non-permissive conditions for 4h or 6h. Samples were immediately centrifuged 
and resuspended in PBS containing 10% glycerol, fixed with 37% formaldehyde for 10 
min., and washed and resuspended in PBS plus 10% glycerol. Cells were visualized as 
described above. Localization of GFP-tagged proteins was quantitated in Adobe 
Photoshop by counting cells with localized or mislocalized exocyst subunits. “Localized” 
was defined as a distinct patch at the bud tip or mother-daughter neck of budding cells, 
and “mislocalized” as diffuse or patchy staining in the cytoplasm or mother cell. For each 
strain and condition, n > 100 cells were counted for 3 replicates each. 
Immunoprecipitations  
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 Yeast were grown to an O.D.600 of 1.0 at 25ºC and samples were incubated with 
shaking at 37ºC for 3 h. 50 O.D. of each sample were pelleted and resuspended in 200 µL 
of lysis buffer (50 mM  sodium phosphate pH 7.4, 150 mM NaCl, 0.5% IGEPAL, 1 mM 
EDTA, 1 mM DTT, 1 mM PMSF, 0.7 µg/mL pepstatin, 1 µg/mL leupeptin, 1µg/mL 
chymostatin, 1µg/mL antipain, 1µg/mL aprotinin) and lysed by vortexing for 3 min in a 
50% slurry containing 0.5 mm zirconia/silica beads (BioSpec Products). Lysate was 
centrifuged at 13,000 rpm to remove cell debris. The supernatant was pre-cleared for 1h 
at 4ºC with 30 µL protein A beads (Roche), and then incubated with α-MYC (Covance), 
α-HA (Roche) or α-GFP (Abcam) antibody and fresh protein A beads for 2h in lysis 
buffer.  Beads were washed using 3 x 1 mL of chilled lysis buffer. Beads were 
resuspended in 100 µL of loading dye and proteins separated by SDS-PAGE. Proteins 
were transferred to nitrocellulose and probed with appropriate antibodies. Western blots 
were developed using horseradish peroxidase-conjugated α-rabbit IgG (Roche), followed 
by chemiluminescent detection (ECL; Amersham) using an LAS-3000 (Fujifilm) running 
Image Reader LA-3000 (Fujifilm). For binding of Sec1p to recombinant Sec6p, the 
Sec1p-V5-His6 immunoprecipitation was performed with 50 O.D. 600 of yeast expressing 
a galactose inducible Sec1-V5-His6 
70 resuspended in wash buffer (50 mM Hepes pH7.4, 
20 mM NaN3, 20 mM NaF). Cells were then pelleted, resuspended in lysis buffer, lysed, 
and bound to protein A beads using -V5 antibody, as described above. Immobilized 
Sec1-V5-His6 was washed with binding buffer lacking protease inhibitors, and incubated 
for two hours with 1 µM purified recombinant His6-Sec6p (in 10% glycerol, 10 mM 
K2HPO4, 100 mM KH2PO4, 140 mM KCl, pH 7.4, see below) and washed with binding 
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buffer without protease inhibitors. Samples were resuspended in 100 µL of SDS loading 
dye, boiled, separated by SDS-PAGE, and analyzed by Western Blot as described above. 
For ultracentrifugation experiments, 200 µL of each lysate was centrifuged for 20 min at 
50,000 rpm (105,000 x g) in a Beckman Optima TL ultracentrifuge. The supernatants 
were removed, and the pellet was resuspended in 200 µL of lysis buffer. The presence of 
Sec1p, Sec9p and exocyst subunits in the supernatant and pellet fractions were detected 
by Western blot analyses, as above. Immunoprecipitation experiments were performed as 
above, using the supernatant fraction rather than complete lysate. 
Crosslinking and Mass Spectrometry 
 Recombinant His6-Sec6p and Sec9CT (Sec9p residues 416-651) protein 
purifications were performed as described 65. This C-terminal domain of Sec9p is 
homologous to the mammalian t-SNARE SNAP-25, and is sufficient for function in yeast 
46. Purified Sec6p and Sec9CT were incubated at 3 mg/mL for 1h at 4ºC in 100 mM MES 
buffer to pre-form the Sec6p-Sec9CT complex. The “zero-length” cross-linking agent 
EDC (1-Ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride), was dissolved to 
0.1 M in deionized water, and added in combination with N-hydroxysulfosuccinimide  
(0.1 M) as per 146. Crosslinking proceeded at room temperature for 1h, and the reaction 
was quenched with an excess of 2-mercaptoethanol. After separation by SDS-PAGE and 
Coomassie staining, the cross-linked and non-cross-linked bands were excised. Western 
blot analysis was used to verify that both proteins were present in the cross-linked bands. 
Samples of Sec6p and Sec9CT were then subjected to chymotryptic in-gel digestion (50 
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ng/µL) in the presence or absence of heavy water (
18
O) for 16h at 30ºC as described in 147. 
Heavy water (
18
O) was used in order to label peptides and cross-links. Peptides digested 
in the presence of 
18
O water will be 4 mass units larger than those digested in the 
presence of 
16
O water, while cross-linked peptides will be 8 mass units larger. Digested 
samples were purified using an Omix C18 ZipTip reverse-phase cleanup tip. The ZipTip 
was prewashed with 50% acetonitrile and equilibrated with 0.1% trifluoroacetic acid. 
Peptides were bound to the ZipTip by aspirating 5 times. The ZipTip was then washed by 
repeated aspiration with 10 µL of 0.1% TFA, and eluted by aspiration with 50% 
acetonitrile. Eluant was spotted (1 µL) onto a Matrix-assisted laser desorption/ionization 
time-of-flight mass spectrometry (MALDI-TOFMS) target plate with 1µL of α-cyno-4-
hydroxycinnaminic acid matrix at 10 mg/mL in 50% acetonitrile, 0.1% TFA, and then 
allowed to air dry. MALDI-TOFMS analysis was performed on Waters MALDI L/R 
MALDI-TOF mass spectrometer in reflectron mode to acquire spectra from m/z 400-
6000.  The instrument was calibrated by lock mass calibration using a pre-defined 
mixture of peptides in the lock mass well. Between 15 and 20 spectra were taken for each 
measurement. Each experiment was repeated in triplicate. Peptides were identified from 
their molecular weight and analyzed using GPMAW (General Protein Mass Analysis for 
Windows) and MassLynx software 148. GPMAW was used to match sequences of normal 
and cross-linked peptides observed in MALDI-TOF MS analysis. Mass identity 
assignment of cross-linked peptides was made if they met the following criteria: 1) the 
peptide was present in the cross-linked sample and absent in the non-cross-linked sample. 
2) the peptide was present in at least two of three replicates. 3) the peptide resulted from a 
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chymotrypsin cleavage (Y, W, F, L, M). 4) In the heavy water samples, two 
18
O atoms 
were incorporated into the C-terminus of each peptide. This results in a +4 Da shift in 
linear peptides and a +8 Da shift in cross-linked peptides; cross-linked peptides were 
assigned only if they showed a +8 Da shift.  
 
RESULTS 
Sec6p interacts with Sec9p in vivo 
 Sec6p is an essential exocyst subunit that localizes to sites of polarized secretion 
and interacts with several other exocyst subunits (reviewed in 5). Previously, we defined a 
robust in vitro interaction between recombinant Sec6p and the plasma membrane t-
SNARE Sec9p; in the absence of additional factors, this interaction appears to negatively 
regulate SNARE complex assembly in vitro 65. These results suggest a direct role for a 
subunit of the exocyst complex in regulating SNARE complex assembly. In order to 
determine if the Sec6p-Sec9p interaction occurs in vivo, we constructed yeast strains in 
which the wild-type copies of SEC6 or SEC9 were replaced with low copy CEN plasmids 
containing SEC6-MYC13 or SEC9-HA3 (Table 2.1). Both strains expressed the tagged 
proteins at levels comparable to endogenous, as detected by Western blot analyses. To 
test the Sec6p-Sec9p interaction in yeast, Sec6p-Myc was immunoprecipitated with -
Myc antibody, and the presence of Sec9p was assayed using α-Sec9p antibody. We found 
that Sec9p coimmunoprecipitated specifically with Sec6p-Myc (Figure 2.1A).  
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Figure 2.1 Sec6p interacts with Sec9p in vivo. (A) Immunoprecipitations from yeast 
lysate carrying Sec6p-Myc as the sole copy of Sec6p. Bound proteins were detected by 
Western blot analyses with α-Sec6p and α-Sec9p antibodies. Sec9p runs as a doublet; 
both bands are detected by α-Sec9p. (B) Sec9p-HA was immunoprecipitated, and the 
bound fraction was probed for the presence of Sec6p. Untagged SEC6 and SEC9 strains 
were used as negative controls. For all immunoprecipitation experiments, 1% of the total 
cell lysate, and 10% of the bound material were run on SDS-PAGE and the presence of 
indicated proteins were detected by Western blot analyses. 
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Conversely, when we immunoprecipitated Sec9p-HA with -HA antibody, we found that 
it coimmunoprecipitated Sec6p (Figure 2.1B), demonstrating that the Sec6p-Sec9p 
interaction exists in vivo. 
 
Mutations in the N-terminal domain of Sec6p Lead to Growth and Secretion Defects 
 To explore the Sec6p-Sec9p interaction further, we performed cross-linking 
experiments, combined with mass spectroscopy, to isolate interacting regions. We 
incubated recombinant His6-Sec6p and Sec9CT (residues 416-651, which are 
homologous to SNAP-25) together at 4ºC for 1h before cross-linking the proteins using 
the “zero-length” crosslinker EDC (1-Ethyl-3-[3-dimethylaminopropyl]carbodiimide 
hydrochloride, Pierce) 146. Samples were proteolyzed to completion with chymotrypsin in 
normal water or heavy water (
18
O) before analysis by reflectron MALDI-TOF mass spec. 
Cross-linked fragments were identified as described in Materials and Methods. Our 
analysis revealed a single putative pair of cross-linked peptides:  Sec6p TSARDFQE 
(MW 951.96 Da, a.a. 150-157) and Sec9p QRKNVLEKAKRY (MW 1531.78 Da, a.a. 
568-579). This residue is not a typical chymotryptic peptide, but results from a non-
specific cleavage. These residues in Sec6p lie in the N-terminal region, consistent with 
previous data showing that the C-terminal domain alone is not sufficient for Sec9p 
binding in vitro 65. The cross-linked peptide of Sec9p lies centered in the long loop region 
between the two SNARE motifs 121. There are currently no identified mutations in this 
region, though there are conserved residues both in the region and downstream, as 
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mutational analysis has focused largely on the SNARE motifs of this protein 29,46. It 
remains unclear if there is a function to the loop beyond linking the SNARE motifs. 
 To elucidate the function of the exocyst and the Sec6p-Sec9p interaction in yeast, 
we designed mutants in Sec6p that we deemed likely to disrupt this interaction. The 
Sec6p peptide contains several highly conserved charged residues:  R153, D154, and 
E157. We reasoned that charge reversal mutations in this region might result in 
significant disruption of Sec6p-Sec9p interaction. Therefore, we made the following 
mutations in the context of full length Sec6p:  R153D (sec6-43), D154R (sec6-44), and 
the triple mutant Q156K/E157K/Q158K (sec6-46). These mutations are in the N-terminal 
region of the protein, whereas prior temperature sensitive mutations were in the C-
terminal region (Figure 2.2A). We then substituted the mutant sec6 alleles for wild-type 
in yeast and tested for growth and secretion phenotypes. All three mutant strains 
displayed wild-type growth rates at 25ºC on both SC and YPD media. However, at 37ºC 
the growth of the mutant strains was impaired (Figure 2.2B). Growth curves of mutants in 
liquid YPD at 37ºC revealed that this growth defect did not become apparent until 
approximately 4h after the temperature shift (Figure 2.2C). Because preliminary results 
indicated that the growth, secretion, and localization phenotypes of sec6-43 and sec6-44 
were similar, further analyses were only carried out with the sec6-44 and sec6-46 alleles. 
 To elucidate the growth defects of the mutant sec6 strains, we assayed the secretion 
of a typical secretory marker protein, the periplasmic sucrase enzyme invertase. Invertase 
is transported in high density secretory vesicles, a class of vesicles that can be separated 
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Figure 2.2 sec6 mutant strains have altered growth and secretion phenotypes at 
37 C. (A) Location of sec6 temperature sensitive mutations in the Sec6p protein. 
Indicated are the new sec6 alleles in the N-terminal domain:  sec6-43 (R153D), sec6-44 
(D154R), and sec6-46 (Q156K/E157K/Q158K). Other previously characterized sec6 
alleles are sec6-4 15
 
 (L633P), and the patch mutants sec6-49 (L418A, Y422A, W433A, 
Q470A, Q474A) and sec6-54 87 (D607A, T632A, E635R, Y636A, D639R), which are 
located in the Sec6p C-terminal domain whose structure was previously determined 88. 
(B) Serial dilutions of wild-type and sec6 mutants were spotted onto YPD media and 
incubated at 25 C and 37 C. (C) Growth curves for the wild-type SEC6 strain vs. the 
sec6 mutants in YPD at 37 C. Before 4h, growth of the mutants is similar to the wild-
type. One representative growth curve is shown for each strain. (D) sec6 mutants show 
only a minor defect in invertase secretion at 4h. Invertase secretion was assayed at 
permissive and non-permissive temperatures at the time points listed. sec6-4 is only 
shown at the early time point, as a positive control for the block in secretion of invertase. 
(E) Analysis of internal vs. external Bgl2 levels reveals a substantial secretion defect after 
4h at 37ºC. Quantitation of the internal bands is shown below the blots. Each experiment 
was performed in triplicate. 
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from a low density population via Nycodenz gradient fractionation 149. We detected no 
significant defect in invertase secretion in sec6-44 or sec6-46 yeast after 4h at the non-
permissive temperature (Figure 2.2D). However, after 6h, an ~75% drop in invertase 
secretion was observed (Figure 2.2D). This is in stark contrast with other temperature 
sensitive exocyst mutations, such as sec6-4 (Figure 2.2D), or sec10-2, which disrupt 
invertase secretion within minutes after transfer to the restrictive temperatures 150,15, 
suggesting that the 6h defect in invertase secretion might be a secondary effect.  
 We also assayed secretion of the endo- -1,3-glucanase cell wall component Bgl2p, 
which is trafficked in the more abundant, lower density population of secretory vesicles, 
which are distinct from the invertase-containing vesicle population 149. In wild-type yeast, 
100% of the Bgl2p is secreted 150 (Figure 2.2E). However, both sec6-44 and sec6-46 
display a significant defect in Bgl2p after 4h at the non-permissive temperature (Figure 
2.2E). The reduction in Bgl2p secretion (~54%) by the sec6-44 mutant after 4h was 
similar to the disruption by sec6-4 after 1h under restrictive condition. The sec6-46 
mutant displays a more severe (~65%) defect after 4h at 37 C, with a slight (~8%) defect 
observed even at the permissive temperature. Secretion of Bgl2p at 3h was similar to 
wild-type, indicating that the onset of the Bgl2p secretion defect is rapid and concurrent 
with the observed growth defect. Similar results were demonstrated with the exo70-35 
and exo70-38 temperature sensitive alleles, which were defective for secretion of Bgl2p-
containing vesicles and not invertase-containing vesicles 150. The difference between 
Bgl2p and invertase secretion suggests that the sec6-44 and sec6-46 mutants have a 
72 
 
specific block in the trafficking of the Bgl2p-containing vesicles at the restrictive 
temperature.  
 One explanation for the detection of growth and secretion defects only after a 4 h 
temperature shift, is that the mutant proteins are destabilized and fail to fold, or are 
degraded prematurely. To test these possibilities, we blocked protein synthesis in wild-
type and mutant yeast using cyclohexamide, and measured Sec6p protein levels at 37 C 
at several time points by Western blot. No significant loss of either wild-type or mutant 
Sec6p was observed within 2h (data not shown), indicating that wild-type and mutant 
Sec6p have half-lives greater than two hours. Further, in later immunoprecipitation 
experiments, the levels of wild-type and mutant proteins were similar, indicating that the 
growth defects were not caused by degradation of destabilized mutant proteins.  
 Because the sec6-44 and sec6-46 mutations were designed to disrupt a putative 
interaction between Sec6p and Sec9p, we predicted that immunoprecipitation of Sec6p-
HA from cells grown at the restrictive conditions would fail to coimmunoprecipitate 
Sec9p.  However, no abrogation of the Sec6p-Sec9p interaction was observed after a shift 
to the non-permissive conditions (4h at 37ºC in YPD; Figure 2.3A). One explanation is 
that the Sec6p-Sec9p complex is disrupted at the restrictive temperature in vivo, but 
reassembles at 4ºC during the immunoprecipitation experiment. To rule out this 
possibility, lysate from cells expressing tagged Sec6p-Myc and untagged Sec9p was 
mixed with lysate from cells expressing tagged Sec9p-HA and untagged Sec6p. Half of 
the mixed lysate was subjected to an α-HA coimmunoprecipitation, while the other half  
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Figure 2.3 Sec6p mutant proteins interact with Sec9p at the restrictive conditions. 
(A) Sec6p and the sec6 mutants were HA3-tagged and immunoprecipitated from cells 
grown at the permissive and restrictive conditions (4h at 37 C). No significant difference 
in the amount of Sec9p was observed in the mutant vs. wild-type strain. (B) Sec6p-Sec9p 
complexes do not form during the immunoprecipitation experiments. Lysates from 
Sec6p-Myc/Sec9p and Sec9p-HA/Sec6p yeast strains were lysed and either 
immunoprecipitated separately, or mixed and immunoprecipitated with α-HA (lanes 3 
and 5) or α-Myc (lanes 4 and 6) antibodies. The experiments were performed at least 3 
times and one representative experiment is shown. 
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was immunoprecipitated with α-Myc. If the complex between Sec6p and Sec9p reforms 
during the course of the experiment, then the Sec6p-Myc protein would 
coimmunoprecipitate the Sec9p-HA in the mixed lysate sample, and vice versa. Our 
results show, however, that Sec6p-Myc only coimmunoprecipitated wild-type Sec9p and 
that Sec9p-HA only coimmunoprecipitated the wild-type Sec6p (Figure 2.3B). These 
results indicate that the Sec6p-Sec9p complex assembles in vivo and not during the 
course of the experiment. Thus, interactions between the mutant Sec6p proteins and 
Sec9p appear not to be disrupted in vivo. It is likely that the peptides identified by the 
cross-linking experiment do not constitute the entire Sec6p-Sec9p binding interface, and 
that these specific point mutations are not sufficient to significantly disrupt the interaction 
in vivo. Attempts to verify this finding with purified recombinant proteins in vitro were 
unsuccessful, as the mutant Sec6p proteins were mostly insoluble when expressed in E. 
coli (data not shown).  
 
Mutant Sec6p Remains Localized while Sec5p, Sec10p, Sec15p are Mislocalized 
 If the Sec6p mutants are not deficient in Sec9p binding, what is causing the growth 
and secretion phenotypes? We previously demonstrated that residues in the C-terminal 
region of Sec6p are essential to maintain proper localization of the exocyst complex via 
interactions with an unidentified putative anchoring protein 87. One explanation for the 
growth and secretion defects observed for the sec6-44 and sec6-46 alleles are that they 
are caused by disruption of interactions with the anchor similar to the sec6-49 and sec6-
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54 mutants 87, resulting in mislocalization of the mutant Sec6p proteins. To test their 
localization, C-terminally HA3-tagged constructs of the wild-type SEC6, sec6-44 and 
sec6-46 were constructed and expressed as the sole copy of Sec6p. The presence of the 
HA tag did not alter the growth rates of the wild-type and mutant Sec6p strains at either 
permissive or restrictive temperatures. Immunofluorescence experiments revealed that 
both the Sec6-44-HA and Sec6-46-HA proteins were properly localized to the bud tips 
and mother-daughter necks under permissive conditions (Figure 2.4). Surprisingly, after 
4h at the non-permissive temperature (YPD at 37 C), the mutant proteins were still 
properly localized. In contrast, the sec6-4 (Figure 2.4), sec6-49 and sec6-54 alleles 
become rapidly mislocalized after only 1h at the non-permissive temperature 87,134. Given 
that the Sec6p proteins in sec6-44 and sec6-46 are still localized at restrictive 
temperatures, in contrast to other Sec6p mutants, we reasoned that the mutant proteins 
still interact with the anchor protein. Additionally, these results indicate that the mutant 
Sec6p proteins are not globally destabilized.  
 We hypothesized that the sec6-44 and sec6-46 mutations are disrupting other 
interaction sites, possibly by attenuating intra-exocyst subunit interactions. To explore 
this possibility, we tested whether the other exocyst subunits remained properly localized. 
We used strains with genomic GFP-tagged exocyst subunits (Table 2.1) 151 carrying either 
wild-type or mutant Sec6p as the sole source of Sec6p protein. We observed that many of 
the exocyst subunits remained properly localized (Figure 2.5A and 2.5B). However, 
Sec5-GFP (~80%), Sec10-GFP (~55%), and Sec15p-GFP (~60%) were mislocalized after 
4h at  
77 
 
Figure 2.4 Sec6p mutants are properly localized at the restrictive conditions. sec6 
mutants remain localized to sites of polarized secretion (bud tips and mother-daughter 
necks) after 4h at 37 C, as assayed by immunofluorescence using α-HA antibodies. In 
contrast, localization of sec6-4 is disrupted after 1h at 37ºC. Panels are representative 
samples. 
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Figure 2.5 The exocyst subunits Sec5p, Sec10p, and Sec15p are mislocalized after 4h 
at 37ºC. (A) Strains contained GFP-tagged exocyst subunits, and either wild-type Sec6p 
or the sec6 mutants as the sole copy of Sec6p. Sec3p, Sec8p, Exo70p, and Exo84p remain 
localized in Sec6p mutants, while GFP tagged Sec5p, Sec10p, and Sec15p are 
mislocalized after 4h at 37ºC. (B) Quantification of the percent of yeast cells with 
mislocalized exocyst-GFP fluorescence. At least three samples of >300 yeast were 
analyzed for each strain. 
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the restrictive temperature. Exo84-GFP also showed a modest (~20%) mislocalization in 
the sec6-46 allele. This mislocalization of only a subset of the exocyst complex differs 
from previous experiments involving sec6-4 and other temperature sensitive exocyst 
mutants, which result in mislocalization of all exocyst subunits 84,95,97. In contrast to those 
findings, our results using the sec6-44 and sec6-46 alleles demonstrate that Sec6p, Sec8p, 
Sec3p, Exo70p and Exo84p remain localized to sites of secretion at the non-permissive 
conditions. 
Mutant Sec6p Subcomplex Contains Sec6p, Sec3p, Sec8p, Exo70p and Exo84p 
 We reasoned that the sec6-44 and sec6-46 mutations might cause destabilization 
and/or disassembly of Sec5p, Sec10p and Sec15p from the exocyst complex. These 
mutant alleles are located in the N-terminal region of Sec6p (Figure 2.2A), which is 
required for interaction with the exocyst subunit Sec8p and the t-SNARE Sec9p 65,88. 
Additionally, the full-length Sec6p interacts with other exocyst subunits, including 
Sec5p, Sec10p and Exo70p (reviewed  in Munson and Novick, 2006). In order to 
examine the assembled state of the exocyst complex, we performed several different 
coimmunoprecipitation experiments. First, using α-HA antibody to immunoprecipitate 
wild-type or mutant Sec6p-HA, we determined which exocyst proteins remain bound to 
Sec6p at permissive vs. non-permissive temperature. Secondly, using Sec8-Myc6 
coexpressed with either mutant or wild-type Sec6p, we monitored the status of the 
assembled exocyst complex independently from those that remained bound to the Sec6-
HA. Coimmunoprecipitation assays corroborated the GFP localization experiments. 
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While most of the exocyst subunits coimmunoprecipitated with either Sec8p-Myc or 
Sec6p-HA after 4h at the non-permissive temperature, there was a selective loss of 
Sec5p, Sec10p, and Sec15p from the complex (Figure 2.6A and 2.6B). The remaining 
subunits, Sec6p, Sec3p, Sec8p, Exo70p and Exo84p reside as an intact subcomplex. To 
investigate whether Sec5p, Sec10p and Sec15p might form a second stable subcomplex, 
we performed similar immunoprecipitation experiments using strains containing Sec5p-
GFP and either wild-type Sec6p or the mutant Sec6p alleles. Immunoprecipitation of 
Sec5-GFP from mutant cells grown at the non-permissive temperature for 4h 
coimmunoprecipitated a small amount of Sec10p and Sec15p, but not Sec6p or Exo70p 
(Figure 2.6C). Thus, there is only a minor Sec5p-Sec10p-Sec15p population at restrictive 
conditions, which suggests that the interactions between these proteins are not very stable 
in the absence of the other exocyst subunits. 
 A trivial explanation for the selective disruption of Sec5p, Sec10p, and Sec15p 
from the exocyst is that disassembly of the subcomplex is a slow phenomenon, and that 
the remaining subunits might disassemble at later time points. To test this possibility, 
coimmunoprecipitation experiments with both Sec6p-HA and Sec8-Myc were repeated 
after 6h at 37ºC in YPD, with identical results (data not shown), suggesting that the sec-
44 and sec6-46 alleles result in a stable exocyst subcomplex at the restrictive temperature, 
rather than complete disassembly. To further confirm this, we monitored the localization 
of the GFP-tagged exocyst subunits (as above) at both 6h and 8h at the restrictive 
temperatures; we observed no additional change in localization.  
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Figure 2.6 Mutant Sec6p proteins form stable exocyst subcomplexes. (A) -HA 
immunoprecipitations of HA3-tagged Sec6p and Sec6p mutants were performed using 
cells grown at 25ºC and 37ºC for 4h. Binding of the exocyst subunits Sec5p, Sec10p and 
Sec15p, as well as the regulatory protein Sec1p, is reduced in the mutant strains at the 
restrictive conditions. However, binding of Sec3p, Exo70p and Exo84p is similar to wild-
type. (B) -Myc immunoprecipitation of the exocyst complex with Sec8-Myc shows 
similar results to the Sec6p immunoprecipitations in A, except that Sec1p is not bound. 
Sec9p also shows no significant amount of co-immunoprecipitation with Sec8-Myc. (C) 
Immunoprecipitation of Sec5-GFP with -GFP indicates that Sec5p is only weakly 
assembled with Sec10p and Sec15p at the restrictive conditions. (D) Suppression of the 
sec6-46 growth phenotype by overexpression of exocytic SNAREs and exocyst subunits. 
2µ URA3 plasmids were transformed into sec6-46; 10-fold serial dilutions were plated 
onto SC-ura and incubated at the indicated temperatures. 
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 To identify candidates for the direct binding partner for these Sec6p residues, we 
examined genetic interactions between these mutants and various late-acting sec mutants. 
Combining these sec6 alleles with other exocyst temperature sensitive mutations resulted 
in synthetic growth defects, but none were significantly more severe than others (data not 
shown). However, the sec6-44 and sec6-46 alleles could be suppressed by overexpression 
of a subset of sec proteins (Figure 2.6D; sec6-46 is shown). 2µ plasmids containing the 
exocytic SNAREs SSO1, SNC2 or SEC9 or the exocyst subunit SEC10 were able to 
weakly suppress the temperature sensitive defect. Overexpression of SEC5, SEC8, 
EXO70 and EXO84 strongly suppressed the growth phenotype. Conversely, 
overexpression of SEC15 had a negative effect on the growth of the sec6 alleles, 
consistent with previously observed detrimental effects upon overexpression of SEC15 on 
wild-type cells 152. Interestingly, the 2µ plasmid expressing the regulator SEC1 also 
suppressed the sec6-46 phenotype, suggesting a possible interaction between Sec6p and 
Sec1p. Because Sec5p is one of the exocyst subunits lost at the non-permissive 
temperature, and is a strong suppressor of the temperature sensitive alleles, we propose 
that Sec5p is the direct binding partner for this region of Sec6p. Currently, the lack of 
soluble recombinant proteins has prevented this from being directly tested; however, this 
conclusion is supported by the presence of a similar exocyst subcomplex found in the 
sec5-24 temperature sensitive strain 80. 
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The Free Pool of Sec6p Interacts with the t-SNARE Sec9p  
 We previously showed that Sec6p is present in both exocyst-bound and free pools 
in vivo 65; our current results suggest that it is this free pool of Sec6p that interacts with 
Sec9p. First, no significant amount of Sec9p was coimmunoprecipitated with Sec8-Myc 
and the exocyst complex (Figure 2.6B), in contrast to the ~10% that 
coimmunoprecipitated with Sec6-HA (Figure 2.3A). Secondly, when Sec9-HA was 
immunoprecipitated from the wild-type SEC6 strain, the only exocyst subunit to 
coimmunoprecipitate was Sec6p (Figure 2.7A). To test this more directly, we performed 
ultracentrifugation experiments to separate the free pool of Sec6p from the exocyst-
bound pool. Yeast lysates were centrifuged at 50,000 rpm (105,000 x g) for 20 min, and 
the supernatant and pellet fractions were tested for the presence of exocyst proteins, as 
well as Sec9p (Figure 2.7B). Sec6p was present in both supernatant and pellet fractions, 
as expected from prior gel filtration results 65, although Sec6p was previously found only 
in the pellet fraction after a 100,000 rpm spin 23. Sec10p and Sec15 were present in both 
the supernatant and pellet fractions as well, as previously shown 23. Sec9p was located 
only in the supernatant fraction, suggesting that it was unlikely to be stably interacting 
with the exocyst. To confirm that Sec9p interacts with the non-exocyst-bound Sec6p, 
immunoprecipitation of Sec6-HA from the supernatant fraction co-immunoprecipitated 
Sec9p but failed to immunoprecipitate Sec10p and Sec15p (Figure 2.7C). We conclude 
from these data that Sec9p interacts with Sec6p when it is not assembled into the exocyst 
complex.  
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Figure 2.7 Sec9p and Sec1p interact primarily with the non-exocyst-bound free pool 
of Sec6p. (A) -HA immunoprecipitations of HA3-tagged Sec9p and were performed. 
Immunoprecipitation of Sec9-HA only coimmunoprecipitates Sec6p. (B) Cells were 
centrifuged for 20 min at 50,000 rpm and the input lysate, pellet and supernatant fractions 
were each tested for the presence of exocyst, Sec1p and Sec9p proteins via western blot 
analyses. Sec9p and Sec1p appear predominantly in the supernatant, separate from the 
exocyst, which appears in the pellet fraction. Sec10p and Sec15p are found in both the 
supernatant and pellet fractions, as shown previously 23. (C) The non-exocyst-bound 
Sec6-HA was immunoprecipitated from the supernatant fraction of A and bound proteins 
were analyzed by western blot. Sec6-HA co-immunoprecipitated Sec1p and Sec9p, but 
not the Sec10p and Sec15p proteins. Experiments were repeated three times. 
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Sec6p Directly Interacts with the SNARE Regulator Sec1p 
 Previously, a weak interaction was observed between the exocytic SM protein 
Sec1p and the exocyst complex 122. Other tethering complexes interact with their partner 
SM proteins:  the vacuolar SM protein Vps33p is a member of the Class C/HOPS 
tethering complex 73,153 and Sly1p, the SM protein that regulates traffic between the ER 
and Golgi, was recently shown to interact with the assembled COG complex 137. When 
we assayed for Sec1p in our immunoprecipitation experiments, Sec6-HA3 
coimmunoprecipitated ~10% of the total Sec1p (Figure 2.6A). Interestingly, the Sec8-
Myc immunoprecipitation from wild-type Sec6p cells did not coimmunoprecipitate any 
significant amount of Sec1p (Figure 2.6B). This differs from previous results in which a 
minor amount (~0.2 - 0.4%) of Sec1p was bound to the exocyst complex (unless Sec1p 
was overexpressed), as monitored by coimmunoprecipitation with Sec8-Myc or Sec10-
Myc 122. However, our experiments used approximately one-sixth of the total amount of 
yeast cells compared to the prior experiments. We repeated our coimmunoprecipitation 
experiments using Sec8-Myc cells at the higher cell concentration and obtained similar 
results to the previously published data. These data suggest that Sec6p directly interacts 
with Sec1p, but Sec1p may also have weak interactions with other exocyst subunits. Data 
from the sec6-46-HA3 mutant supports the idea of a direct Sec6p-Sec1p interaction; at the 
non-permissive temperature, Sec1p does not coimmunoprecipitate with sec6-46 (Figure 
2.6A). In addition, the sec6-46 phenotype was strongly suppressed by overexpression of 
Sec1p (Figure 2.6D). Furthermore, when Sec6-HA was immunoprecipitated from the 
ultracentrifuged lysates (as performed above with Sec9p), Sec6-HA co-
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immunoprecipitated Sec1p from the supernatant fraction (Figure 2.7C). Together, these 
data reveal that the free, non-exocyst-bound pool of Sec6p interacts with Sec1p.  
 To determine if the interaction between Sec1p and the exocyst is directly mediated 
through Sec6p, we immunoprecipitated yeast Sec1-V5-His6 
70 using an -V5 antibody, 
and subsequently tested binding of the immobilized Sec1p to recombinant purified His6-
Sec6p (Figure 2.8). In the V5 immunoprecipitation, a fraction of the endogenous Sec6p is 
coprecipitated in the absence of additional Sec6p (+buffer lane). The bound Sec1p was 
washed thoroughly with binding buffer and then incubated with excess recombinant His6-
Sec6p; a substantial amount of the recombinant Sec6p bound to the Sec1p. As a negative 
control, we incubated purified Sso1p with the immobilized Sec1p and did not detect any 
Sso1p binding. Sso1p is the other exocytic t-SNARE; in the absence of the Sec9p and 
Snc2p SNARE proteins, it does not interact with Sec1p 70. Together, these results support 
the hypothesis that Sec1p binds directly to Sec6p, and, like the Sec6p-Sec9p interaction, 
the majority of the Sec6p-Sec1p interaction involves the non-exocyst-bound pool of 
Sec6p.  
93 
 
Figure 2.8 Purified recombinant Sec6p binds to immobilized Sec1p-V5-His6. Sec1p-
V5-His6 was immunoprecipitated with -V5 antibody and washed 3 times with binding 
buffer. In vitro purified His6-Sec6p was then incubated with the immobilized Sec1p, 
unbound protein was washed off, and bound proteins detected by Western blot analysis. 
An untagged SEC1 strains was used as a negative control (lane 3). Lane 4 is a buffer 
control in which no His6-Sec6p was added, to show the amount of endogenous yeast 
Sec6p bound to the immobilized Sec1p after washing. The t-SNARE Sso1p, which does 
not bind to Sec1p in the absence of the other SNAREs 70, is shown as a negative control. 
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DISCUSSION 
We identified a novel class of temperature sensitive sec6 alleles in the N-terminal region 
of Sec6p (Figure 2.2A) that specifically disrupt exocyst complex assembly and/or 
stability without disrupting polarized localization. Immunoprecipitation experiments 
indicated that Sec9p interacts with a non-exocyst bound pool of Sec6p in vivo, and not 
with exocyst-bound Sec6p (Figure 2.1, Figure 2.7A and C), and that the sec6 mutations 
by themselves are not sufficient to disrupt the Sec6p-Sec9p interaction (Figure 2.3A). 
Instead, these mutants disrupt an interaction within the exocyst complex, leaving a stable 
subcomplex consisting of Sec6p, Sec3p, Sec8p, Exo70p and Exo84p localized to sites of 
growth and secretion.  
 The mutations in Sec6p result in a temperature sensitive growth phenotype (Figure 
2.2B and C), and show a block in Bgl2p secretion concurrent with the visible growth 
defect, while exhibiting a delayed defect in invertase secretion (Figure 2.2D and E). 
Bgl2p is an endo-B-1,3-glucanase and major component of the yeast cell wall 154. Bgl2p 
is transported in a population of lower density secretory vesicles, while invertase is found 
in a higher density population 149. In many different trafficking mutants that lead to an 
accumulation of secretory vesicles, the cargo of higher density vesicles continues to be 
secreted 155. This suggests that these higher density vesicles (as marked by invertase) may 
not be as sensitive to the state of the regulatory machinery as the lower density vesicles, 
which carry material specifically for membrane and cell wall expansion. Similar results 
were observed for the exo70-35 and exo70-38 mutants 150, which had a selective defect in 
Bgl2p secretion although they continued to secrete invertase-containing vesicles. 
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 Under non-permissive conditions, the mutant Sec6p proteins remained properly 
localized (Figure 2.4), consistent with our previous identification of residues in the C-
terminal domain of Sec6p that are critical for anchoring the complex at sites of secretion 
87. Most of the other subunits of the exocyst were also localized. Only Sec5p, Sec10p, and 
Sec15p showed significant mislocalization (Figure 2.5). Coimmunoprecipitation of the 
exocyst complexes using tagged Sec6p or Sec8p showed similar results; Sec5p, Sec10p 
and Sec15p did not remain bound to the Sec6p subcomplex at the non-permissive 
temperature (Figure 2.6). This Sec6p-Sec3p-Sec8p-Exo70p-Exo84p subcomplex may 
provide a direct link between sites of secretion on the plasma membrane and the Sec15p-
Sec10p subcomplex on secretory vesicles 23. 
 Which subunit of the exocyst interacts with these N-terminal Sec6p residues? The 
strongest candidate to bridge the plasma membrane and vesicle-bound components of the 
exocyst is Sec5p. This conclusion is supported by the previously observed in vitro 
interaction between Sec5p and Sec6p 23, and the strong suppression of the sec6-44 and 
sec6-46 mutant phenotypes observed upon overexpression of SEC5 (Figure 2.6D). 
Sec10p is also a possibility; however, we previously showed that the C-terminal region of 
Sec6p alone is sufficient for binding to Sec10p in vitro 88. It is likely that Sec10p is lost 
from the complex indirectly due to the loss of Sec5p, which also interacts with Sec10p 23. 
Sec15p has not been shown to interact directly with Sec6p or Sec5p, but is likely 
disrupted from the complex through its interaction with Sec10p 23. Overexpression of 
other subunits that remain bound to the mutant Sec6p proteins (SEC8, EXO70, and 
EXO84) also suppresses the mutants, likely by stabilizing the mutant proteins and 
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interactions, and thus stabilizing the interaction of Sec6p with Sec5p. Together, these 
results indicate that while the C-terminal region of Sec6p functions to regulate 
localization of the complex 87, the N-terminal region of Sec6p functions as an interaction 
core for exocyst complex assembly and maintenance. Thus, Sec6p would anchor the core 
exocyst subunits at the plasma membrane, and with Sec5p, would bridge to the vesicle-
associated Sec15p-Sec10p proteins, to directly tether vesicles to the plasma membrane 
before fusion. Consistent with these dual functions, we observed that a Sec6p protein 
containing the combined mutations from the N-terminal sec6-46, and C-terminal sec6-54 
alleles, was completely non-functional as the sole copy of Sec6p in yeast (data not 
shown).  
 We also identified a direct interaction between Sec6p and the exocytic SM protein 
Sec1p (Figure 2.8). The sec6-46 mutation disrupts interactions between Sec6p and Sec1p 
at the non-permissive temperature (Figure 2.6A), and its temperature sensitive growth 
defect is suppressed by overexpression of SEC1 (Figure 2.6D). SM proteins are 
regulators of SNARE complex assembly and fusion 66, and Sec1p specifically interacts 
with the assembled exocytic SNARE complex 70. The Sec6p-Sec1p interaction may serve 
to recruit Sec1p to sites of secretion, as this function cannot be provided by its cognate 
syntaxin Sso1p 70. Also, the interaction may add further regulation and specificity to the 
fusion process. In other systems, interactions between tethering complexes and SM 
proteins are required for proofreading SNARE complexes or for SNARE complex 
formation 53,61,137. We previously showed that the Sec6p-Sec9p interaction slowed 
formation of binary SNARE complexes in vitro and hypothesized that missing cofactors 
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would be necessary to stimulate assembly (Sivaram et al., 2005). Sec1p could be one of 
those cofactors, functioning similarly to Sly1p in its interactions with the COG complex 
to stimulate formation of the SNARE complex 137. A functional interaction between 
Sec1p and Sec6p is consistent with the recent finding that Sec1p is required upstream of 
SNARE complex assembly 72. 
 The interactions of Sec6p with the t-SNARE Sec9p and the SNARE regulatory 
protein Sec1p take place predominantly in the absence of the assembled exocyst complex 
(Figure 2.6, Figure 2.7, Figure 2.8). Prior to vesicle arrival and exocyst complex 
assembly, Sec6p could function to prevent premature SNARE complex assembly. In the 
presence of the other exocyst subunits and Sec1p, Sec6p would function to anchor the 
assembled exocyst complex and may, in collaboration with Sec1p, facilitate proper 
SNARE complex assembly. This could explain the disruption of exocyst assembly when 
residues that crosslink between Sec6p and Sec9p are mutated. If binding to Sec6p is a 
competitive process between Sec5p and Sec9p then assembly of the exocyst would 
disengage Sec6p from Sec9p releasing any inhibition caused by Sec6p. The free pool of 
Sec6p may interact with Sec1p in order to recruit a small amount of that protein to the 
assembling exocyst. Testing of these models requires further biochemical and genetic 
studies to explore whether the Sec1p interaction with Sec6p occurs concurrently with the 
Sec6p-Sec9p interaction, and what effect Sec1p and Sec6p have on exocyst and SNARE 
complex assembly in vitro and in vivo.  
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Chapter III: 
 
Conclusions, Future Directions, 
and the Future of the Field 
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Discussion 
In all eukaryotes, the basic functioning of cells, growth and survival, requires the 
proper trafficking of cargo between membrane-bound organelles and the plasma 
membrane. Exocytosis and endocytosis require multiple classes of proteins, including 
tethering factors, SNARE proteins, and SM proteins to control and regulate these 
processes both temporally and spatially 1,156. Most of these proteins are essential, defects 
in any protein class leads to disease or death, and every new discovery reveals further 
reaching effects of trafficking into less obviously trafficking linked systems 127,12,13,59. 
Understanding trafficking systems – their defects, the diseases they cause, and 
discovering treatments – requires elucidation of the basic interactions between the 
proteins involved, both in vitro and in vivo.   
The field of trafficking is fast progressing; the huge body of collective knowledge 
is growing to the point where smaller and smaller answers lead us to larger and larger 
conclusions. Each individual discovery reveals multiple missing pieces of the puzzle. 
Characterization of individual interactions between proteins allows the construction of 
larger models that lead toward a paradigm of trafficking systems biology, a complete 
system-wide model. To build an effective paradigm for trafficking, we must understand 
the interactions and regulation networks between the SNARE proteins, SM proteins, and 
tethering factors. The more individual trafficking interactions we characterize both in 
vivo and in vitro the clearer it becomes that many of the mechanisms, structures, and 
functions of the proteins involved are conserved.  
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In this thesis I have focused on the in vivo interactions between three proteins in 
one step of trafficking, exocytosis to the plasma membrane. I have clarified the 
interactions between the SM protein, Sec1p, the SNARE protein Sec9p and the tethering 
complex subunit Sec6p creating a picture of conservation of function if not the finer 
points of mechanism by demonstrating SM:tethering complex:SNARE interactions. 
Tethering complexes and their subunits interact with both SNARE and SM proteins along 
with other factors to form a regulatory network that ensures fidelity of fusion. The 
conclusions reached in the previous chapter of my thesis shine light on questions both 
large and small, while also raising many new questions and possibilities.  
The purpose of large tethering complexes has been a considerable and vexing 
question challenging the field. As more individual interactions are elucidated, these large 
complexes are revealed both as members and as focal points of complex, dynamic 
interaction networks. These networks form a multilayer system that regulates the last 
steps of trafficking and fusion. Subunits function both as members of and external to their 
complexes. And now, Sec6p joins this paradigm, through its interactions both within the 
exocyst, and with external proteins such as Sec9 (Figure 2.1), Sec1p (Figure 2.8), and the 
anchor 87.  
The identification of a stable subcomplex of the exocyst is a novel discovery. 
Prior mutations that cause complex disruption have displayed semi-stable  or unstable 
subcomplexes and have not been explored further 5,23. Further, the sec6-44 and sec6-46 
mutants appear to selectively block only one branch of the secretory pathway, the Bgl2p 
102 
 
pathway, while leaving the invertase pathway unaffected until six hours (Figure 2.3D and 
E). This selective block is similar to that shown in certain Exo70p mutants 150. The 
possibilities this raises are intriguing. The interaction between Sec6p and Sec5p is 
disrupted (Figure 3.1 i) in the sec6-44 and sec6-46 mutants, which leads to loss of Sec5p, 
Sec10p, and Sec15p from the complex (Figure 3.2). Though the loss of Sec5p, Sec10p, 
and Sec15p causes an immediate block in Bgl2p secretion (Figure 2.3D) invertase 
secretion continues as normal for another several hours (Figure 2.3E). This is surprising 
given that the loss of Sec15p and Sec10p via the disruption of Sec5p:Sec6p interaction 
(Figure 3.2) apparently denies vesicles a direct connection to the target membrane.  This 
result suggests that at least some vesicles can continue to fuse using only a subcomplex 
of the exocyst that is not directly interacting with the vesicle. One possibility for the 
delay in complete cessation of secretion is that the lack of fusion of the Bgl2p-carrying 
vesicles causes slow depletion of factors on the membrane required for fusion of the 
vesicles that otherwise can fuse utilizing only a subcomplex of the exocyst. Another 
possibility is that the Bgl2p pathway is simply more sensitive to perturbations in exocytic 
function. This could be the case if the Bgl2p pathway requires more properly assembled 
exocyst, for instance. 
Previously, we knew that Sec6p interacted with the t-SNARE Sec9p. However, 
the Sec6p:Sec9p interaction appeared to inhibit the formation of the binary t-SNARE 
complex, which is essential for formation of a fusion-competent SNARE complex 42,65. 
The identification of a hypothesized factor required for in vivo function has been elusive. 
An assembled exocyst complex could be required, but has not been reconstituted  
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Figure 3.1 Schematic of disrupted Sec6p:Sec5p interaction in sec6-44 and sec6-66 
mutants and Sec6p:Sec1p interaction in the sec6-66 mutant. Sec5p interaction (i) with 
Sec6p is abrogated in mutants, disrupting exocyst assembly/maintenance. Sec1p:Sec6p 
interaction may also be disrupted in the sec6-46 mutant (o) 
104 
 
105 
 
 
Figure 3.2 Schematic of loss of fusion in sec6-44 and sec6-66 mutants. Sec6p:Sec5p 
interaction is disrupted, causing the loss of Sec5p, Sec10p, and Sec15p from the complex. 
The connection between the vesicle and the plasma membrane is lost, and any tethering 
function is disrupted. The mutations in Sec6p are represented by a yellow star. 
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in vitro yet.  Until my recent experiments, it was possible that the Sec6p:Sec9p 
interaction might be an artifact of the in vitro assay rather than an interaction that occurs 
in vivo. That is now clearly not the case, as I have demonstrated a robust in vivo 
interaction between Sec6p and Sec9p via in vivo immunoprecipitations of each protein 
(Figure 2.1). Though I expected to find Sec9p interacting with the exocyst via Sec6p, I 
instead found that the interaction between Sec6p and Sec9p involves the previously 
identified “free pool” of Sec6p 65. The absence of Sec9p bound to exocyst 
immunoprecipitated via Myc-Sec8 (Figure 2.6B) and ultracentrifugation which shows 
Sec9p present only in the supernatant fraction (Figure 2.7) demonstrate this. The function 
of this interaction, however, remains unclear. Sec6p may be sequestering Sec9p from 
interaction with Sso1p, preventing premature formation of the binary SNARE complex 
before the arrival and tethering of vesicles. Or perhaps, the Sec6p:Sec9p interaction 
involves a third protein, required for proper SNARE complex assembly. SNARE 
assembly assays conducted in the presence of assembling exocyst and other factors will 
help to shed light on this possibility. Additionally, mutants in Sec6p that disrupt the Sec9 
interaction will help elucidate the function of this interaction in vivo. 
A growing theme in the field has become the interaction between tethering 
complexes and SM proteins. Some SM proteins are even included among the subunits of 
their relevant tethering complex 53,66-68. Similarly the SM protein Sec1p interacts with the 
exocyst complex, though only weakly unless Sec1p is overexpressed 122.  On closer 
inspection, it now appears that Sec1p interaction with the exocyst complex occurs 
through Sec6p, which interacts directly with Sec1p (Figure 2.8). And that this interaction 
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preferentially utilizes the free pool of Sec6p (Figure 2.7). Interaction between the exocyst 
complex and Sec1p appears to be minimal when compared to that with Sec6p. The 
function of this interaction requires further study. The well defined functions of Sec1p 
and other SM proteins involve SNARE complex assembly and fusion, but my Sec6p 
coimmunoprecipitation of Sec1p does not simultaneously coimmunoprecipitate Snc2p or 
Sso1p. Additionally, Sec1p only interacts with the complete SNARE complex 70,71. These 
data suggest that the Sec6p:Sec1p interaction occurs prior to SNARE complex assembly. 
This conclusion is supported by recent genetic data suggesting that Sec1p has an as yet 
unidentified function prior to SNARE assembly 72. SNARE assembly assays in the 
presence of both Sec1p and Sec6p will determine whether this interaction is required for 
proper SNARE assembly. Further mutants that disrupt Sec6p:Sec1p interaction may also 
be useful. 
The direct in vivo interactions described here raise many further questions even as 
they answer others. Sec6p interacts directly with Sec1p (Figure 2.8), and the t-SNARE 
Sec9p (Figure 2.1), and with the unidentified anchor protein 87.Could these interactions 
occur simultaneously? Perhaps Sec1p is required for proper SNARE assembly, the third 
factor suggested to work with Sec6p to enhance SNARE complex assembly.  In 
conjunction with Sec6p, Sec1 may enhance SNARE assembly to in vivo levels (Figure 
3.3A). This possibility is compelling, but Sec1p does not interact with Sec9p or Sso1p 
except as a member of the complete SNARE complex 71,118. However, if Sec6p interacts 
simultaneously with both Sec1p and Sec9p, then a direct interaction between Sec1p and 
Sec9p may not be required. This model would, however, require yet a third factor to  
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Figure 3.3 Models for Sec1p:Sec6p:Sec9p interaction. A) Sec6p interacts 
simultaneously with Sec9p and Sec1p and a third factor, possibly the opener, to control 
SNARE complex assembly. B) SNARE complex assembly is a concerted action, rather 
than stepwise as occurs in vitro. C) Sec6p interaction prevents Sec9p from forming 
SNARE complex with Sso1p opened by a localized and promiscuous opener. Exocyst 
assembly dislocates Sec6p from Sec9p allowing SNARE assembly to proceed. 
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interact with Sso1p (Figure 3.3A). Perhaps it is the hypothesized” opener” protein that 
releases Sso1p autoinhibition 41,42.  
There is a remote possibility that the in vivo formation of the SNARE complex is 
a concerted reaction and that the apparent order of in vitro assembly is an artifact of the 
assay. That is, in vitro the syntaxin t-SNARE Sso1p opens, binds to its partner t-SNARE 
Sec9p, and then the complex binds the final motif from the v-SNARE Snc2p, initiating 
fusion. in vivo this sequence may occur rapidly. In this case, all the players are waiting 
just offstage, possibly bound to other factors, for the maestro Sec1p to start the play. 
When Sec1p raises its baton and signals, the proteins all swoop in at once from their 
factors to bind Sec1p as a complete SNARE complex (Figure 3.1B). However, in this 
model, Sec6p would be expected to coimmunoprecipitate Sso1p, but no 
coimmunoprecipitation is displayed. Additionally, the closed formation of Sso1p and 
requirement for an opener protein 115 makes this possibility seem unlikely. To examine 
these possibilities, SNARE assembly assays with the SNARE proteins, as well as Sec1p 
and Sec6p must be performed. Ideally, other potential factors such as the complexed 
exocyst could be added. However, many of the exocyst subunits still defy purification. 
Previously, SNARE assembly assays have been performed largely with the t-SNARES 
because opening of the syntaxin t-SNARE Sso1p is the rate-limiting step 41,42. However, 
given that Sec1p interacts with the complete SNARE complex, assays involving Sec1p 
would likely require a complete set of SNARE proteins – Sec9p, Sso1p, and Snc2p.  
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A final hypothesis, and the one currently best supported by the evidence, is that 
Sec6p inhibition of SNARE complex assembly is not an artifact, despite my original 
hypothesis that it was. In this model, Sec6p binds to Sec9p before the arrival of the 
vesicle, thus preventing premature formation of the binary t-SNARE complex. With the 
arrival of the vesicle, and newly synthesized exocyst components 98, the exocyst 
assembles from a mix of new and disassembled subunits. Exocyst assembly causes Sec6p 
to dissociate from Sec9p to enter the complex, freeing Sec9p. Sec9p, Sso1p, and Snc2 
then form the SNARE complex, uninhibited (Figure 3.1C). This hypothesis is consistent 
with the current data both in vitro and in vivo. The overlap of the putative Sec6p:Sec9p 
interaction region revealed by mass spectrometry and the Sec6p:Sec5p interaction region 
revealed by the sec6-44 and sec6-46 mutations supports a competitive model where 
Sec5p interaction with Sec6p, exocyst assembly, releases Sec9p from Sec6p. However, 
Sec6p appears localized to sites of secretion, not the entire membrane, as is Sec9p. The 
“opener” for Sso1 may be localized to sites of secretion and is promiscuous, opening 
Sso1p prematurely. This open Sso1p would create a requirement for inhibition of 
SNARE complex formation prior to arrival of the vesicle, possibly by Sec6p.The free 
pool of Sec6p may also be distributed across the plasma membrane, without sufficient 
density to compare to the foci of polarized exocytosis. As Sec6p:Sec9p interaction 
utilizes the free Sec6p pool, FRET between Sec6p and Sec9p may be an effective way to 
test the localization of the free pool of Sec6p. One further detail that requires some 
explanation is that Boyd et al. identified Sec6p as being trafficked with the vesicle 98, 
implying that final exocyst assembly at the membrane would not cause free Sec6p to 
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dissociate from Sec9p.  However, Boyd et al. did not see any retrograde traffic of exocyst 
components. Given the extended halflife of Sec6p noted in this thesis, we assume that 
significant exocyst assembly and disassembly occurs at sites of secretion if there is no 
significant retrograde trafficking of subunits. The remaining question in this model, then, 
is the function of Sec6p:Sec1p interaction (and possible exocyst interaction). One 
possibility is that Sec6p is recruiting Sec1p for the upstream function suggested by 
Hashizume et al (2009). Additionally, interaction with Sec6p may protect Sec9p from 
proteolysis, though Sec9p is not localized to sites of secretion as Sec6p appears to be. 
Ideally, SNARE assembly experiments could be performed with both wild type 
and the sec6-46 mutant protein that disrupts the Sec1p:Sec6p interaction. However, the 
triple mutation in the N-terminal region of Sec6p appears to destabilize the already 
“sticky” N-terminal region sufficiently to make the mutant resistant to in vitro expression 
and purification. The disruption of the interaction between Sec6p and Sec1p by the sec6-
46 mutation does raise further questions.  Where does the Sec6p:Sec1p interaction occur 
on Sec1p? What is the structure of the N-terminal region of Sec6p that interacts with 
Sec1p? Could Sec6p be utilizing the large binding cleft of Sec1p that is the main binding 
site on other SM proteins for SNARE interaction with the SM protein? Alternatively, 
perhaps the N-terminal region of Sec6p binds to Sec1p on the opposite face of Sec1p in 
order to change the conformation of Sec1p and encourage SNARE complex assembly. 
Also, given that Sec1p overexpression rescues the phenotypes of sec6-44 and sec6-46 
mutants, does that overexpression rescue exocyst assembly? If so, why? Interaction 
assays using in vitro expressed proteins with mutations in conserved regions of Sec1p 
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might allow greater elucidation of the location of Sec1p:Sec6p interaction surfaces. 
However, Sec1p has proven somewhat resistant to large-scale purification, though our lab 
has promising results with Sec1p purified from yeast. The possibility of a crystal 
structure of Sec6p interacting with Sec1p is titillating, but unlikely due to difficulties with 
purification of the N-terminal region of Sec6p and Sec1p.  
Though SM proteins were thought to differ extensively with respect to binding 
mode, as more quantitative in vitro methods are used we see that many of those 
differences are disappearing 69. And despite their differences all SM proteins interact with 
cognate SNAREs 66,67. The apparent differences between SM proteins may be small and 
mechanistic encouraging fidelity while the proteins conserve the same overall function. 
The emerging function of SM proteins is that of a master regulator of SNARE complex 
assembly, regulating fusion via multiple interactions with tethers and SNAREs, 
conserved across multiple trafficking steps. 
To be sure, some differences between trafficking steps will remain. Differences in 
fine mechanistic detail between various tethering complexes, SNAREs, and SM proteins 
are essential. If interactions between all tethers and their cognate SNARES were 
identical, the fidelity and specificity necessary for cell survival would be lost. The 
individual demands of certain steps will call for slight variations in mechanism. For 
example, synaptic release – a highly specialized, and temporal and volumetric specific 
function of secretion and exocytosis – requires far more specific and layered regulation in 
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the docking step of the pathway than does the constitutive process of growth and budding 
in yeast.  
Interestingly, as I demonstrate in this thesis, the portion of Sec6p that appears to 
be responsible for Sec9p interaction 65 is also a region critical to maintenance of a stable, 
complete exocyst complex. This likely ensures that Sec9p cannot interact with Sec6p 
while Sec6p is functioning as an exocyst subunit. The interaction region will be buried in 
the exocyst, perhaps with the sticky, intractable N-terminal regions of other subunits. 
This suggests that the exocyst complex is probably not directly involved in any regulation 
that Sec6p:Sec9p interaction is responsible for, though assembly regulates the 
Sec6p:Sec9p interaction. The fact that a free pool of Sec6p is required to interact with 
Sec1p and Sec9p also raises an interesting question about similarly structured proteins: 
Are there free pools of other proteins with similar folds? Clearly fold is not the only 
determinant, as only Sec6p, Sec10p, and Sec15p are found in free pools of exocyst 
subunits (Figure 2.7B). Size-exclusion fractionation of yeast lysate followed by western 
blots would allow exploration of this possibility. Some tethering complexes clearly 
interact directly with their SM proteins, rather than via a free pool of a subunit 61,137; but 
the question is, to what purpose? Is this difference simply an evolutionary accident, or a 
result of a difference in mechanism or function?  
The recent discovery of a putative anchoring protein that interacts with Sec6p 87 
raises some engaging questions that dovetail with those raised by this thesis: What is the 
anchor? How does its role fit into that of Sec6p? The anchor may simply hold the exocyst 
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at sites of polarized secretion. However, the anchor could also act to secure/localize the 
free pool of Sec6p, which leads to yet another question: Is Sec6p anchored when 
interaction with Sec1p occurs? When Sec6p:Sec9p interaction occurs? My hypothesis is 
that Sec1p:Sec6p:Sec9p interaction occurs simultaneously. The free pool of Sec6p would 
then inhibit premature SNARE complex formation, while recruiting Sec1p to sites of 
secretion for its as yet unknown pre-docking function. This seems a likely hypothesis as 
the mechanism of Sec1p recruiting to sites of secretion is unknown, and the suggestion of 
a function prior to docking only enhances that question. Elucidation of the order or 
simultaneity of Sec6p, Sec9p, Sec1p, and anchor interactions is an essential next step in 
understanding the final steps of exocytosis, and possibly of trafficking in general. Studies 
will involve the immunoprecipitation and in vivo assays with yeast that combine anchor 
mutants such as sec6-54 with Sec1p interaction mutants such as sec6-46. Successful 
disruption of the Sec6:Sec9p interaction via mutant proteins will also be essential to fully 
elucidate the function of that interaction. 
Further, the role that the Sec6p dimer plays in the cell is still elusive. It has been 
demonstrated in vitro and suggested in the in vivo free pool 65 but the function remains 
unknown. Does the dimer truly exist in vivo? Perhaps dimerization is required to stabilize 
the N-terminal region of the protein when Sec6p is not interacting with multiple other 
exocyst subunits. Perhaps despite prior evidence 78 Sec6p is a dimer in the exocyst 
complex. Coexpression of truncations of Sec6p in the presence of wild-type Sec6p may 
allow for better elucidation of the dimer, and other intra and extra exocyst interactions. 
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Final Conclusions 
 The work presented in my thesis has contributed significantly to the 
understanding of the role of the exocyst subunit Sec6p in exocytosis, as well as 
elucidating further the roles of Sec9p and Sec1p. Though prior studies had suggested that 
Sec5p was the structural core of the exocyst, I identified point mutations in Sec6p that 
result in the formation of a previously unidentified stable subcomplex. Surprisingly, this 
subcomplex can exist in the absence of Sec5p, Sec10p, and Sec15p. This subcomplex is 
the first demonstrated persisting subcomplex of the exocyst. I also showed that the 
growth defect caused by exocyst disruption displays a delayed onset, and, prior to a 
disruption in invertase secretion, blocks Bgl2p secretion. The delay in growth-defect 
onset suggests an intriguing division of function between portions of the exocyst, similar 
to that previously identified in mutants in Exo70p 150.  
 Further, I showed that the previously demonstrated in vitro interaction between 
Sec6p and Sec9p occurs in vivo as well, but that it involves the free pool of Sec6p, rather 
than exocyst-bound Sec6p. Similarly, this free pool of Sec6p interacts directly with the 
SM protein Sec1p. These results raise compelling possibilities for the regulation of 
SNARE complex assembly and membrane fusion, and, to elucidate this system, suggest 
further experiments. The direct interaction between the free pool of Sec6p and Sec9p as 
well as Sec1ps suggests further lines of inquiry in mammalian systems, especially the 
neuronal system where the extent of exocyst involvement has remained unclear. Does 
Sec6p serve to regulate SNARE complex assembly via SNAP25 in mammalian cells as 
118 
 
well? Is the inhibitory effect of Sec6p perhaps even more critical in mammals where 
syntaxin maintains a more open state than Sso1p? My results and conclusions expand the 
knowledge of the field and serve to further the formation of a unified paradigm of 
trafficking function. 
119 
 
 
Appendix I: 
 
Sec8 Methods 
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Sec8p is the essential, 121kD subunit of the exocyst complex 78. Sec8p has been 
implicated in both morphological differentiation of oligodendrocytes and Schwann cell 
differentiation 157,131. Sec8 deletions are embryonic lethal in mice, and fail to develop past 
gastrulation 158. 
Within to the exocyst, I showed that Sec8p interacts directly with Sec6p and that 
the C-terminal region is insufficient for this interaction 88. Based on the interaction 
between Sec6p and Sec8p, I hypothesized that Sec8p might play a role in regulating 
interaction between Sec6p and Sec9p, thus regulation of SNARE complex assembly. This 
hypothesis was formed prior to the data in this thesis demonstrating that Sec6p:Sec9p 
interaction utilized the free pool of Sec6p.  
In order to explore this hypothesis and elucidate the role of Sec8p in the exocyst, I 
designed multiple constructs of Sec8 for expression in E. coli based on secondary 
structure predictions (Figure A1.1). Expression was attempted under multiple conditions 
(Table A1.1) but was largely unsuccessful, most proteins failed to express or aggregated 
on purification columns. A small quantity of full length, Sec8-His6 construct could be 
purified in order to perform qualitative interaction studies 88. However this construct 
resisted further purification and scaling efforts. More recently, a His6 form of one of the 
constructs, Sec8NT4 (a.a. 19-459) has been purified using a denaturing procedure 
(QiaExpressionist). Cells are lysed at RT in denaturing lysis buffer (100mM NaH2PO4, 
10mM Tris, 6M guanidine hydrochloride, pH 8.0) and pelleted. The supernatant is  
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Figure A1.1 Constructs of Sec8p for in vitro protein expression. Various constructs of 
Sec8p comprising various regions of the protein, based on predicted secondary structure 
were designed.  
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Table A1.2 Sec8 Constructs for in vitro purification 
Construct Final Column Buffer Notes 
8N Ni Beads His Wash Buffer 1, 2, 7, 8 
MBP8 Ni Beads MBP Lysis Buffer 3 
GST8 Ni Beads GST Lysis Buffer 3 
Yeast 8N 
(GAL) 
Ni Beads His Wash Buffer 3 
8NT1N Ni Beads His Wash Buffer 3 
8NT2N Ni Beads His Wash Buffer 3 
8CT1N Ni Beads His Wash Buffer 3 
8CT2N Ni Beads His Wash Buffer 1, 4,5, 6, 7, 8 
8CT2N Sup75 His Wash Buffer 2 
8NT3N MonoQ 200mM HEPES, pH 7.0 9 
8NT4N MonoQ 200mM HEPES, pH 7.0 9 
8NT5N NA NA 12 
8NT6N Ni Beads/Sup75 His Wash/ Tris pH 7.5 3,13 
8NT7N NA NA 12 
8CT3N Ni Beads His Wash Buffer 3 
8CT4N Ni Beads His Wash Buffer 3, 14 
8CT5N Sup200 Tris pH 7.5 2, 3, 11 
8CT6N Ni Beads His Wash Buffer 3 
8CT7N NA NA 12 
8CT8N NA NA 12 
Baculovirus NA NA 10 
 
1 – Enough for bead binding 
2 – Copurifies with heat shock proteins 
3 – Insufficient protein to continue purification 
4 – Binds to MonoQ column 
5 – Binds to Sup6 column 
6 – Binds to Hydrophobic column 
7 – Buffers at pH 6.5, 7.5, 8.0  
8 – Coexpression with MBP6 does not improve purification 
9 – Binds to Sup200 
10 – Cloning incorrect 
11 – Protein in void fraction 
12 – Insufficient protein expression 
13 – Degrades during purification 
14 – Denaturing prep successful (performed by Ashleigh Wood) 
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nutated for one hour with Ni beads and washed with denaturing wash buffer with 
successively lower pH (100mM NaH2PO4, 10mM Tris, 8M urea,  pH 6.3, pH 5.9, pH 4.5) 
before being dialyzed into potassium phosphate buffer. There is currently no assay for 
folding, so we can’t use this protein for functional studies, it is being used to create what 
will hopefully be the first Sec8p antibody in the field. 
In addition to constructs designed for E. coli, I designed full length constructs for 
S. cerevisiae and for baculovirus expression in insect SF9 cells. A His6-tagged Sec8 
construct was cloned into 2µ URA3 PGAL1 and CEN URA3 PGAL1 expression vectors 
(pPP639 and pPP1247, respectively), and transformed into wild type yeast in addition to 
the genomic copy of Sec8p. The plasmid was maintained by growth on selective media. 
Colonies were suspended in liquid synthetic complete media lacking leucine or uracil and 
grown at 25ºC and 30ºC. I determined that Sec8-His6 can be expressed in yeast under the 
galactose inducible promoter without causing growth defects in liquid culture, but 
expression remains low and expressed protein is not amenable to purification.  
Baculovirus expression in insect cells was attempted using the Bac-to-Bac system 
by Invitrogen, utilizing the HisBIVT and 3ATR plasmids. SF9 cells were cultured in 
SF900 II Serum Free Media (Invitrogen). Cells were cultured without difficulty as per 
standard directions; however, success with the baculovirus vector was prevented by 
difficulties with infection and vector shuffling. No significant expression was displayed; 
however I was unable to demonstrate viral infection and thus that the virus contained the 
Sec8 clone. I suspect that the problem was in the cloning process. This was not a 
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methodology familiar to the lab. Though unsuccessful, baculovirus expression may yet 
prove an effective means of expressing Sec8 and other exocyst proteins in more 
experienced hands.  
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